Document and Entity Information	9 Months Ended
Document and Entity Information	Dec. 31, 2012	Jan. 31, 2013
Entity Information [Line Items]
Entity Registrant Name	Prestige Brands Holdings, Inc.
Entity Central Index Key	0001295947
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		51,052,340

Consolidated Statements of Income and Comprehensive Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Revenues
Net sales	$ 159,492	$ 105,799	$ 466,735	$ 304,678
Other revenues	740	451	2,349	2,411
Total revenues	160,232	106,250	469,084	307,089
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	75,235	51,128	209,938	148,193
Gross profit	84,997	55,122	259,146	158,896
Operating Expenses
Advertising and promotion	23,538	15,274	67,371	38,580
General and administrative	11,378	13,655	40,114	32,366
Depreciation and amortization	3,359	2,563	9,950	7,683
Total operating expenses	38,275	31,492	117,435	78,629
Operating income	46,722	23,630	141,711	80,267
Other (income) expense
Interest income	(4)	(1)	(9)	(4)
Interest expense	26,665	8,117	66,178	24,977
Gain on settlement	0	0	0	(5,063)
Total other expense	26,661	8,116	66,169	19,910
Income before income taxes	20,061	15,514	75,542	60,357
Provision for income taxes	7,804	6,004	29,386	23,130
Net income	12,257	9,510	46,156	37,227
Earnings per share:
Basic (in USD per share)	$ 0.24	$ 0.19	$ 0.91	$ 0.74
Net income (in USD per share)	$ 0.24	$ 0.19	$ 0.90	$ 0.73
Weighted average shares outstanding:
Basic (in shares)	50,686	50,307	50,465	50,256
Diluted (in shares)	51,523	50,684	51,285	50,667
Comprehensive income, net of tax:
Currency translation adjustments	(1)	(18)	23	(70)
Total other comprehensive income (loss)	(1)	(18)	23	(70)
Comprehensive income	$ 12,256	$ 9,492	$ 46,179	$ 37,157

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2012	Mar. 31, 2012
Current assets
Cash and cash equivalents	$ 10,431	$ 19,015
Accounts receivable, net	73,752	60,228
Inventories	54,250	51,113
Deferred income tax assets	6,594	5,283
Prepaid expenses and other current assets	6,195	11,396
Total current assets	151,222	147,035
Property and equipment, net	9,190	1,304
Goodwill	167,546	173,702
Intangible assets, net	1,375,938	1,400,522
Other long-term assets	27,493	35,713
Total Assets	1,731,389	1,758,276
Current liabilities
Accounts payable	40,858	26,726
Accrued interest payable	13,620	13,889
Other accrued liabilities	34,272	23,308
Total current liabilities	88,750	63,923
Long-term debt
Principal amount	1,007,500	1,135,000
Less unamortized discount	(7,200)	(11,092)
Long-term debt, net of unamortized discount	1,000,300	1,123,908
Deferred income tax liabilities	185,007	167,717
Total Liabilities	1,274,057	1,355,548
Commitments and Contingencies — Note 17
Stockholders' Equity
Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None	0	0
Preferred share rights	283	283
Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 51,201 shares at December 31, 2012 and 50,466 shares at March 31, 2012	512	505
Additional paid-in capital	400,316	391,898
Treasury stock, at cost - 181 shares at December 31, 2012 and March 31, 2012	(687)	(687)
Accumulated other comprehensive income (loss), net of tax	10	(13)
Retained earnings	56,898	10,742
Total Stockholders' Equity	457,332	402,728
Total Liabilities and Stockholders' Equity	$ 1,731,389	$ 1,758,276

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Stockholders' Equity:
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	51,201,000	50,466,000
Treasury stock, shares	181,000	181,000

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Operating Activities
Net income	$ 46,156	$ 37,227
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,950	7,683
Deferred income taxes	15,979	7,321
Amortization of deferred financing costs	8,220	847
Stock-based compensation costs	2,965	2,360
Amortization of debt discount	3,892	687
Lease termination costs	975	0
Loss on disposal of equipment	51	0
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(13,518)	(5,816)
Inventories	(3,351)	(3,850)
Prepaid expenses and other current assets	5,801	2,650
Accounts payable	14,125	2,392
Accrued liabilities	9,631	(3,508)
Net cash provided by (used in) operating activities	100,876	47,993
Investing Activities
Purchases of property and equipment	(8,922)	(358)
Proceeds from escrow of Blacksmith acquisition	0	1,200
Proceeds from the sale of property and equipment	15	0
Proceeds from the sale of the Phazyme brand	21,700	0
Acquisition of brands from GSK purchase price adjustments	(226)	0
Net cash provided by investing activities	12,567	842
Financing Activities
Repayments of long-term debt	(167,500)	(58,000)
Repayments under revolving credit agreement	(8,000)	0
Borrowings under revolving credit agreement	48,000	0
Proceeds from exercise of stock options	5,460	572
Shares surrendered as payment of tax withholding	0	(271)
Net cash used in financing activities	(122,040)	(57,699)
Effects of exchange rate changes on cash and cash equivalents	13	(31)
Decrease in cash and cash equivalents	(8,584)	(8,895)
Cash and cash equivalents - beginning of period	19,015	13,334
Cash and cash equivalents - end of period	10,431	4,439
Interest paid	54,149	28,503
Income taxes paid	$ 7,183	$ 12,699

Business and Basis of Presentation

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business and Basis of Presentation

Nature of Business

Prestige Brands Holdings, Inc. (referred to herein as the “Company” or “we”, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct and indirect wholly-owned subsidiaries on a consolidated basis) is engaged in the marketing, sales and distribution of over-the-counter (“OTC”) healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets and dollar and club stores primarily in the United States and Canada and in certain other international markets. Prestige Brands Holdings, Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 10 to the Consolidated Financial Statements.

Basis of Presentation

The unaudited Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in the Consolidated Financial Statements. In the opinion of management, the Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments that are considered necessary for a fair presentation of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31^st of each year. References in these Consolidated Financial Statements or notes to a year (e.g., “2013”) mean our fiscal year ending or ended on March 31^st of that year. Operating results for the three and nine months ended December 31, 2012 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2013. This financial information should be read in conjunction with our Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2012.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from these estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, sales returns and allowances, trade promotional allowances and inventory obsolescence.

Cash and Cash Equivalents

We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents. Substantially all of our cash is held by a large regional bank with headquarters in California. We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.

Accounts Receivable

We extend non-interest-bearing trade credit to our customers in the ordinary course of business. We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable. In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers' financial condition, (iii) monitor the payment history and aging of customers' receivables, and (iv) monitor open orders against an individual customer's outstanding receivable balance.

Inventories

Inventories are stated at the lower of cost or market value, with cost determined by using the first-in, first-out method. We reduce inventories for diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include: (i) current sales data and historical return rates, (ii) estimates of future demand, (iii) competitive pricing pressures, (iv) new product introductions, (v) product expiration dates, and (vi) component and packaging obsolescence.

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

* Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset.

Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.

Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Goodwill

The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in purchase business combinations is classified as goodwill. Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Goodwill is tested for impairment at the reporting unit “brand” level, which is one level below the operating segment level.

Intangible Assets

Intangible assets, which are comprised primarily of trademarks, are stated at cost less accumulated amortization. For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives ranging from 3 to 30 years.

Indefinite-lived intangible assets are tested for impairment at least annually in the fourth fiscal quarter of each year. Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts exceed their fair values and may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.

Deferred Financing Costs

We have incurred debt origination costs in connection with the issuance of long-term debt. These costs are capitalized as deferred financing costs and amortized using the effective interest method, over the term of the related debt. For a further discussion regarding accelerated amortization, refer to Note 10.

Revenue Recognition

Revenues are recognized when the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the selling price is fixed or determinable, (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss, and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when product is received by the customer, and, accordingly, we recognize revenue at that time. Provisions are made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience.

As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. At the completion of a promotional program, the estimated amounts are adjusted to actual results.

Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.

Cost of Sales

Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs. Shipping, warehousing and handling costs were $7.6 million and $23.1 million for the three and nine months ended December 31, 2012, respectively, and $6.9 million and $20.1 million, respectively, for the three and nine months ended December 31, 2011.

Advertising and Promotion Costs

Advertising and promotion costs are expensed as incurred. Allowances for new distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these new distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees.

Stock-based Compensation

We recognize stock-based compensation by measuring the cost of services to be rendered based on the grant-date fair value of the equity award. Compensation expense is recognized over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period.

Income Taxes

Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Income Taxes topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, we have applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.

We are subject to taxation in the United States and various state and foreign jurisdictions.

We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.

Earnings Per Share

Basic earnings per share is calculated based on income available to common stockholders and the weighted-average number of shares outstanding during the reporting period. Diluted earnings per share is calculated based on income available to common stockholders and the weighted-average number of common and potential common shares outstanding during the reporting period. Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options, stock appreciation rights and unvested restricted shares, are included in the earnings per share calculation to the extent that they are dilutive.

Recently Issued Accounting Standards

In July 2012, the FASB issued guidance regarding testing the impairment of indefinite-lived intangible assets other than goodwill. The new guidance is intended to simplify how entities test impairment of indefinite-lived intangible assets other than goodwill. The new guidance permits an entity to first assess qualitative factors to determine whether it is "more-likely-than-not" that the fair value of the asset is less than its carrying amount as a basis for determining whether it is necessary to perform the impairment test described in the ASC Intangibles-Goodwill and Other topic. The more-likely-than-not threshold is defined as having a likelihood of more than 50%. The new guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted. We do not expect that the adoption of this new guidance will have a material impact on our Consolidated Financial Statements.

In December 2011, the FASB issued guidance regarding disclosures about offsetting assets and liabilities. The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position, as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. An entity will be required to disclose the following information for assets and liabilities within the scope of the new standard: (i) the gross amounts of those recognized assets and those recognized liabilities; (ii) the amounts offset to determine the net amounts presented in the statement of financial position; (iii) the net amounts presented in the statement of financial position; (iv) the amounts subject to an enforceable master netting arrangement or similar agreement not otherwise included in (ii); and (v) the net amount after deducting the amounts in (iv) from the amounts in (iii). The standard affects all entities with balances presented on a net basis in the financial statements, derivative assets and derivative liabilities, repurchase agreements, and financial assets and financial liabilities executed under a master netting or similar arrangement. This guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. We do not expect the adoption of this new guidance to have a material impact on our Consolidated Financial Statements. However, our arrangement with GlaxoSmithKline plc ("GSK"), as discussed in Note 2 to the Consolidated Financial Statements, provided that, during the term of the arrangement, we would receive a net monthly remittance, and therefore, we have reported a net amount due from GSK in our accounts receivable at March 31, 2012 of $8.4 million. Since the arrangement ended June 30, 2012, we do not have any amounts due from GSK in our accounts receivable at December 31, 2012.

In June 2011, the FASB issued guidance regarding presentation of comprehensive income. Under the ASC Comprehensive Income topic, entities are allowed the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income. This guidance eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This guidance does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income.

In December 2011, the FASB issued guidance to defer the new requirement to present components of reclassifications of other comprehensive income on the face of the income statement. Based on this guidance, entities are still required to adopt either the single continuous statement or the two-statement approach required by the new guidance. However, entities should continue to report reclassifications out of accumulated other comprehensive income consistent with the requirements in effect before the adoption of the new standard (i.e., by component of other comprehensive income, either by displaying each component on a gross basis on the face of the appropriate financial statement or by displaying each component net of other changes on the face of the appropriate financial statement with the gross change disclosed in the notes). The new guidance and this deferral were effective for the Company beginning with the three months ended June 30, 2012, and full retrospective application is required. The December 2011 deferral of the guidance issued in June 2011, as well as the June 2011 guidance, are effective at the same time. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

In September 2011, the FASB issued guidance regarding testing goodwill for impairment. The new guidance is intended to simplify how entities test goodwill for impairment. The new guidance permits an entity to first assess qualitative factors to determine whether it is "more-likely-than-not" that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in the ASC Intangibles-Goodwill and Other topic. The more-likely-than-not threshold is defined as having a likelihood of more than 50%. The new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

Management has reviewed and continues to monitor the actions of the various financial and regulatory reporting agencies and is currently not aware of any other pronouncement that could have a material impact on our consolidated financial position, results of operations or cash flows.

- Definition

The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.

+ References+ Details

Acquisitions

9 Months Ended

Dec. 31, 2012

Business Combinations [Abstract]

Acquisitions

Acquisition of GlaxoSmithKline OTC Brands

On December 20, 2011, we entered into two separate agreements with GSK to acquire a total of 17 North American OTC healthcare brands (the "GSK Brands") for $660.0 million in cash (the "GSK Agreement").

On January 31, 2012, we completed, subject to a post-closing inventory and apportionment adjustment, as defined in the GSK Agreement, the acquisition of 15 North American OTC healthcare brands previously owned by GSK and its affiliates (the “GSK Brands I”) for $615.0 million in cash, including the related contracts, trademarks and inventory. The GSK Brands I include, among other brands, BC, Goody's and Ecotrin brands of pain relievers; Beano, Gaviscon, Phazyme, Tagamet and Fiber Choice gastrointestinal brands; and the Sominex sleep aid brand. We acquired the GSK Brands I pursuant to the terms of the GSK Agreement.

On March 30, 2012, we completed, subject to a post-closing inventory and apportionment adjustment, as defined in the GSK Agreement, the acquisition of the Debrox and Gly-Oxide brands (the “GSK Brands II”) in the United States for $45.0 million in cash, including the related contracts, trademarks and inventory.

Both the GSK Brands I and GSK Brands II are complementary to our existing OTC healthcare portfolio.

These acquisitions were accounted for in accordance with the Business Combinations topic of the ASC, which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition.

The purchase price of the GSK Brands I and GSK Brands II was funded by cash provided by the issuance of long-term debt and additional bank borrowings, which are discussed further in Note 10 to the Consolidated Financial Statements. In April 2012, we received the post-closing inventory and apportionment adjustments, which required an additional $2.8 million to be paid to GSK, and in May 2012 we received a revised post-closing inventory and apportionment adjustment, which required an additional $0.2 million, for a total of $3.0 million, to be paid to GSK.

Concurrent with the closing of the GSK Brands I transaction, we entered into a Transitional Services Agreement with GSK (the “TSA”), whereby GSK provided us with various services including: marketing, operations, finance and other services from the GSK Brands I acquisition date primarily through June 30, 2012, with additional finance support through August 31, 2012. As part of the TSA, GSK, among other things, shipped products, invoiced customers, collected from customers and paid certain vendors on our behalf. Our initial costs under the TSA were approximately $2.5 million per month for the length of the agreement and were reduced during the service period as we removed certain services and transitioned these processes to us. For the three and nine months ended December 31, 2012, we incurred zero and $6.9 million, respectively, in TSA costs. Pursuant to this arrangement, we received on a monthly basis the amount owed to us for revenues and expenses, net of GSK's TSA fees and inventory that GSK purchased on our behalf.

The allocation of the purchase price to assets acquired is based on a valuation we performed to determine the fair value of such assets as of the acquisition date. The following table summarizes our allocation of the $663.0 million purchase price to the assets we acquired on the GSK Brands I and GSK Brands II (collectively, the "GSK Brands") acquisition dates:



(In thousands)	GSK Brands I (January 31, 2012)		GSK Brands II (March 30, 2012)		Total
Inventory	$	14,820	$	250	$	15,070
Prepaid expenses	3,575		—		3,575
Trade names	542,892		81,257		624,149
Goodwill	17,401		2,831		20,232
Total purchase price	$	578,688	$	84,338	$	663,026

We recorded goodwill based on the amount by which the purchase price exceeded the fair value of assets acquired. The amount of goodwill deductible for tax purposes is $20.2 million.

The fair value of the trade names is comprised of $556.9 million of non-amortizable intangible assets and $67.2 million of amortizable intangible assets. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 19.3 years. The weighted average remaining life for amortizable intangible assets at December 31, 2012 was 18.2 years.

The operating results of the GSK Brands I have been included in our Consolidated Financial Statements beginning February 1, 2012, while the operating results of the GSK Brands II have been included in our Consolidated Financial Statements beginning April 1, 2012. Revenues of the acquired operations for the three and nine months ended December 31, 2012 were $56.9 million and $159.9 million, respectively, and net income was $8.7 million and $18.4 million, respectively.

The following table provides our unaudited pro forma revenues, net income and net income per basic and diluted common share as if the results of GSK's operations had been included in our operations commencing on April 1, 2011, based upon available information related to GSK's operations. This pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the GSK acquisition been consummated at the beginning of the period for which the pro forma information is presented, or of future results.



(In thousands, except per share data)	Three Months Ended December 31, 2011		Nine Months Ended December 31, 2011

Revenues	$	157,789	$	461,705
Net income	$	17,204	$	54,724

Earnings per share:
Basic	$	0.34	$	1.09

Diluted	$	0.34	$	1.08

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph F4

-Subparagraph e

-Appendix F

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51, 52

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 67-73

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 88-16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

+ Details

Divestitures

9 Months Ended

Dec. 31, 2012

Discontinued Operations and Disposal Groups [Abstract]

Divestitures

Sale of the Phazyme Brand

On October 31, 2012, we divested the Phazyme gas treatment brand, which was a non-core OTC brand that we acquired from GSK in January 2012. We received $21.7 million on October 31, 2012 and the remaining $0.6 million was received on January 4, 2013. The proceeds were used to repay debt. No significant gain or loss was recorded as a result of the sale.

Concurrent with the completion of the sale of the Phazyme brand, we entered into a Transitional Services Agreement with the buyer (the “Phazyme TSA”), whereby we agreed to provide the buyer with various services including: marketing, operations, finance and other services from the date of the acquisition date primarily through January 31, 2013, with additional support for the Canadian portion of that business through March 31, 2013, which may be extended, at the buyer's option, through October 31, 2013 for which fees will be negotiated at such time. As part of the Phazyme TSA, we, among other things, ship products, invoice customers, collect from customers and pay certain vendors on the buyer's behalf. During the quarter ended December 31, 2012, we earned $0.1 million from fees under the Phazyme TSA.

The following table presents the assets sold at October 31, 2012 related to the Phazyme brand:



(In thousands)	October 31, 2012
Components of assets sold:
Inventory	$	220
Prepaid expenses	100
Trade names	15,604
Goodwill	6,382

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43-48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Accounts Receivable

9 Months Ended

Dec. 31, 2012

Receivables [Abstract]

Accounts Receivable

Accounts receivable consist of the following:



(In thousands)	December 31, 2012			March 31, 2012
Components of Accounts Receivable
Trade accounts receivable	$	78,689		$	55,721
Other receivables	1,386			9,368
	80,075			65,089
Less allowances for discounts, returns and uncollectible accounts	(6,323		)	(4,861		)
Accounts receivable, net	$	73,752		$	60,228

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3,4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5074-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5066-111524

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 13

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 9

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5162-111524

+ Details

Inventories

9 Months Ended

Dec. 31, 2012

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following:



(In thousands)	December 31, 2012		March 31, 2012
Components of Inventories
Packaging and raw materials	$	2,375	$	1,189
Finished goods	51,875		49,924
Inventories	$	54,250	$	51,113

Inventories are carried at the lower of cost or market, which includes a reduction in inventory values of $1.8 million and $1.6 million at December 31, 2012 and March 31, 2012, respectively, related to obsolete and slow-moving inventory.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details

Property and Equipment

9 Months Ended

Dec. 31, 2012

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment consist of the following:



(In thousands)	December 31, 2012			March 31, 2012
Components of Property and Equipment
Machinery	$	1,443		$	1,454
Computer equipment	5,398			2,693
Furniture and fixtures	1,523			241
Leasehold improvements	4,712			436
	13,076			4,824
Accumulated depreciation	(3,886		)	(3,520		)
Property and equipment, net	$	9,190		$	1,304

We recorded depreciation expense of $0.4 million and $0.2 million for the three months ended December 31, 2012 and December 31, 2011, respectively, and $1.0 million and $0.6 million for the nine months ended December 31, 2012 and December 31, 2011, respectively. Additionally, during the nine months ended December 31, 2012, we wrote-off leasehold improvements with a remaining net book value of less than $0.1 million due to the relocation of our corporate offices.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

Goodwill

9 Months Ended

Dec. 31, 2012

Goodwill [Abstract]

Goodwill

A reconciliation of the activity affecting goodwill by operating segment is as follows:



(In thousands)	OTC Healthcare			Household Cleaning			Consolidated

Balance — March 31, 2012
Goodwill	$	296,483		$	72,549		$	369,032
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	166,313			7,389			173,702

Additions	226			—			226
Reductions	(6,382		)	—			(6,382		)

Balance — December 31, 2012
Goodwill	290,327			72,549			362,876
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	$	160,157		$	7,389		$	167,546

At March 31, 2012, during our annual test for goodwill impairment, there were no indicators of impairment under the analysis. Accordingly, no impairment charge was recorded in 2012. Additionally, for the nine months ended December 31, 2012, no indicators of impairment existed and no impairment charge was recorded.

The discounted cash flow methodology is a widely-accepted valuation technique to estimate fair value utilized by market participants in the transaction evaluation process and has been applied consistently. We also considered our market capitalization at March 31, 2012, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require impairments in the future.

As discussed in Note 1, in accordance with recent guidance from the FASB, an entity is permitted to first assess qualitative factors in testing goodwill for impairment prior to performing a quantitative assessment. The new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and became effective for the Company in fiscal year 2013. The adoption of this new guidance did not have a material impact on our Consolidated Financial Statements.

During the three months ended June 30, 2012, we received a revised post-closing inventory and apportionment adjustment from GSK for an additional amount of $0.2 million, which resulted in an increase to our recorded goodwill balance.

As more fully discussed in Note 3, on October 31, 2012, we sold the Phazyme Brand for $22.3 million. As a result of the divestiture of Phazyme, we reduced goodwill by $6.4 million.

Intangible Assets

9 Months Ended

Dec. 31, 2012

Intangible Assets [Abstract]

Intangible Assets

A reconciliation of the activity affecting intangible assets is as follows:



(In thousands)	Indefinite Lived Trademarks		Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Carrying Amounts
Balance — March 31, 2012	$	1,245,414	$	217,512		$	158	$	1,463,084
Reductions	—		(16,142		)	—		(16,142		)
Balance — December 31, 2012	$	1,245,414	$	201,370		$	158	$	1,446,942

Accumulated Amortization
Balance — March 31, 2012	$	—	$	62,404		$	158	$	62,562
Additions	—		8,980			—		8,980
Reductions	—		(538		)	—		(538		)
Balance — December 31, 2012	$	—	$	70,846		$	158	$	71,004

Intangible assets, net - December 31, 2012	$	1,245,414	$	130,524		$	—	$	1,375,938

As discussed in Note 3, on October 31, 2012, we sold the Phazyme brand for $22.3 million. As a result of this divestiture, we reduced the net book value of our intangible assets by $15.6 million.

In a manner similar to goodwill, we completed our test for impairment of our indefinite-lived intangible assets during the three months ended March 31, 2012. We did not record an impairment charge, as facts and circumstances indicated that the fair values of the intangible assets for our operating segments exceeded their carrying values. Additionally, for the indefinite-lived intangible assets, an evaluation of the facts and circumstances as of December 31, 2012 continues to support an indefinite useful life for these assets. Therefore, no impairment charge was recorded for the nine months ended December 31, 2012.

The weighted average remaining life for finite-lived intangible assets at December 31, 2012 was approximately 13.0 years and the amortization expense for the three and nine months ended December 31, 2012 was $3.1 million and $9.0 million, respectively. At December 31, 2012, finite-lived intangible assets are being amortized over a period of 3 to 30 years, and the associated amortization expense is expected to be as follows:



(In thousands)
Year Ending March 31,	Amount
2013 (Remaining three months ending March 31, 2013)	$	2,745
2014	10,175
2015	8,840
2016	8,840
2017	8,840
Thereafter	91,084
	$	130,524

- Definition

The entire disclosure for all or part of the information related to intangible assets.

+ References+ Details

Other Accrued Liabilities

9 Months Ended

Dec. 31, 2012

Payables and Accruals [Abstract]

Other Accrued Liabilities

Other accrued liabilities consist of the following:



(In thousands)	December 31, 2012		March 31, 2012

Accrued marketing costs	$	23,151	$	10,554
Accrued compensation costs	6,742		7,181
Accrued broker commissions	550		415
Income taxes payable	—		577
Accrued professional fees	1,724		3,821
Deferred rent	1,091		9
Accrued severance costs	63		461
Accrued lease termination costs	951		290
	$	34,272	$	23,308

Long-Term Debt

9 Months Ended

Dec. 31, 2012

Debt Disclosure [Abstract]

Long-Term Debt

On March 24, 2010, Prestige Brands, Inc. ("the Borrower") issued $150.0 million of senior unsecured notes, with an interest rate of 8.25% and a maturity date of April 1, 2018 (the "2010 Senior Notes"). On November 1, 2010, the Borrower issued an additional $100.0 million of the 2010 Senior Notes. The Borrower may earlier redeem some or all of the 2010 Senior Notes at redemption prices set forth in the indenture governing the 2010 Senior Notes. The 2010 Senior Notes issued in March and November 2010 were issued at an aggregate face value of $150.0 million and $100.0 million, respectively, with a discount to the initial purchasers of $2.2 million and a premium of $0.3 million, respectively, and net proceeds to the Company of $147.8 million and $100.3 million, respectively, yielding an 8.5% effective interest rate for the 2010 Senior Notes on a combined basis. The 2010 Senior Notes are unconditionally guaranteed by Prestige Brands Holdings, Inc. and its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries.

On March 24, 2010, the Borrower entered into a senior secured term loan facility for $150.0 million, with an interest rate at LIBOR plus 3.25% with a LIBOR floor of 1.5% and a maturity date of March 24, 2016 (the "2010 Senior Term Loan"). The $150.0 million 2010 Senior Term Loan was entered into with a discount to lenders of $1.8 million and net proceeds to the Company of $148.2 million, yielding a 5.0% effective interest rate. On November 1, 2010, Prestige Brands Holdings, Inc., together with the Borrower and certain of its other subsidiaries, executed an Increase Joinder to the credit agreement governing the 2010 Senior Term Loan (the "Increase Joinder"), pursuant to which the Borrower entered into an incremental term loan in the amount of $115.0 million. The 2010 Senior Term Loan was scheduled to mature on March 24, 2016 but was repaid in full on January 31, 2012 with the entry into the new senior secured credit facility described below. The 2010 Senior Term Loan was unconditionally guaranteed by Prestige Brands Holdings, Inc. and its domestic 100% owned subsidiaries, other than the Borrower.

Additionally, on March 24, 2010, the Borrower entered into a non-amortizing senior secured revolving credit facility (the “2010 Revolving Credit Facility” and, collectively with the 2010 Senior Term Loan, the “2010 Credit Facility”) in an aggregate principal amount of up to $30.0 million. On November 1, 2010, pursuant to the Increase Joinder, the amount of the 2010 Revolving Credit Facility was increased by $10.0 million, providing the Borrower with borrowing capacity under the 2010 Revolving Credit Facility in an aggregate principal amount of up to $40.0 million. On January 31, 2012, in connection with the entry into the new senior secured credit facility as described below, the Borrower terminated the 2010 Credit Facility. There were no material early termination penalties as a result of the termination of the 2010 Credit Facility.

On January 31, 2012, the Borrower issued $250.0 million of senior unsecured notes at par value, with an interest rate of 8.125% and a maturity date of February 1, 2020 (the "2012 Senior Notes"). The Borrower may earlier redeem some or all of the 2012 Senior Notes at redemption prices set forth in the indenture governing the 2012 Senior Notes. The 2012 Senior Notes are guaranteed by Prestige Brands Holdings, Inc. and certain of its domestic 100% owned subsidiaries. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries. In connection with the 2012 Senior Notes offering, we incurred $12.6 million of costs which were capitalized as deferred financing costs and are being amortized over the term of the 2012 Senior Notes.

On January 31, 2012, the Borrower also entered into a new senior secured credit facility, which consists of (i) a $660.0 million term loan facility (the “2012 Term Loan”) with a seven-year maturity and (ii) a $50.0 million asset-based revolving credit facility (the “2012 ABL Revolver”) with a five-year maturity. In September 2012, we utilized a portion of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $25.0 million to $75.0 million. The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to the Company of $650.1 million. In connection with these loan facilities, we incurred $20.6 million of costs which were capitalized as deferred financing costs and are being amortized over the terms of the facilities. The 2012 Term Loan is unconditionally guaranteed by Prestige Brands Holdings, Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries.

During the three months ended December 31, 2012, as a result of our significant debt repayments, we accelerated a portion of the deferred financing costs and original issue discount related to our 2012 Term Loan. As a result, during the three months ended December 31, 2012, we recorded a $7.7 million pre-tax charge to interest expense related to this non-cash acceleration. Of the $7.7 million, $3.0 million relates to the prior three quarters. Had the timing of the accelerated amortization been properly recorded, pre-tax earnings for the three and nine months ended December 31, 2012 would have been higher by $3.0 million ($1.9 million after tax or $0.03 per diluted share) and $1.1 million ($0.7 million after tax or $0.01 per diluted share), respectively; pre-tax earnings in the first and second quarters of 2013 would have been lower by $1.2 million ($0.7 million after tax or $0.02 per diluted share) and $0.7 million ($0.5 million or $0.01 per diluted share), respectively; and pre-tax earnings in the fourth quarter of 2012 and the year-ended March 31, 2012 would have been lower by $1.1 million ($0.7 million after tax or $0.01 per diluted share). We do not believe the amounts were material to the consolidated financial statements for any prior period and the cumulative amount is not material to the estimated results of operations for the year ended March 31, 2013. Furthermore, the adjustments had no impact to our cash flows from operations or total cash flows.

The 2012 Term Loan bears interest at a rate per annum equal to an applicable margin plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00% and (d) a floor of 2.25% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, provided that LIBOR shall not be lower than 1.25%. For the nine months ended December 31, 2012, the average interest rate on the 2012 Term Loan was 5.4%.

Under the 2012 Term Loan, we are required to make quarterly payments each equal to 0.25% of the original principal amount of the 2012 Term Loan, with the balance expected to be due on the seventh anniversary of the closing date. However, since we made a $25.0 million payment in March 2012, and additional payments totaling $167.5 million during the nine months ended December 31, 2012, we will not be required to make a payment until the maturity date of January 31, 2019.

Borrowings under the 2012 ABL Revolver bear interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs. The initial applicable margin for borrowings under the 2012 ABL Revolver is 1.75% with respect to LIBOR borrowings and 0.75% with respect to base-rate borrowings. The applicable margin for borrowings under the 2012 ABL Revolver may be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter. In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we are required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder. The initial commitment fee rate is 0.50% per annum. The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments in an amount set forth in the credit agreement covering the 2012 ABL Revolver. We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty. For the nine months ended December 31, 2012, the average interest rate on the 2012 ABL Revolver was 2.3%.

We used the net proceeds from the 2012 Senior Notes offering, together with borrowings under the 2012 Term Loan, to finance the acquisition of the GSK Brands I and GSK Brands II, to repay the 2010 Credit Facility, to pay fees and expenses incurred in connection with these transactions and for general corporate purposes. The acquisition of the GSK Brands is discussed in Note 2 to the Consolidated Financial Statements.

In connection with the financing activities of March 2010 relating to the 2010 Senior Notes, the 2010 Senior Term Loan and the 2010 Revolving Credit Facility, we incurred $7.3 million in issuance costs, of which $6.6 million was capitalized as deferred financing costs and $0.7 million was expensed. In connection with the financing activities of November 2010 relating to the 2010 Senior Notes and the Increase Joinder, we incurred $0.6 million in issuance costs, all of which were capitalized as deferred financing costs. In connection with the financing activities of January 2012 relating to the 2012 Senior Notes, the 2012 Term Loan and the 2012 ABL Revolver, we incurred $12.6 million, $18.8 million and $1.8 million, respectively, in issuance costs, which were capitalized as deferred financing costs. The deferred financing costs are being amortized over the terms of the related loan and notes. During the three months ended December 31, 2012, we made significant payments toward our outstanding indebtedness under our 2012 Term Loan. As such, we accelerated a portion of the deferred financing costs related to the 2012 Term Loan in the amount of $5.1 million.

The 2010 Senior Notes are secured on a pari passu basis with the 2012 Term Loan and are guaranteed on a senior unsecured basis. The 2012 Senior Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis. The 2010 Senior Notes are effectively junior in right of payment to all existing and future secured obligations of the Company, equal in right of payment with all existing and future senior unsecured indebtedness of the Company, and senior in right of payment to all future subordinated debt of the Company. The 2012 Senior Notes are effectively subordinated to secured obligations of the Company, including the 2012 Term Loan and the 2012 ABL Revolver and the 2010 Senior Notes, equal in right of payment to all existing and future unsecured obligations of the Company, and senior in right of payment to all existing and future subordinated obligations of the Company.

At any time prior to April 1, 2014, we may redeem the 2010 Senior Notes in whole or in part at a redemption price equal to 100% of the principal amount of the notes redeemed, plus a “make-whole premium” calculated as set forth in the indenture governing the 2010 Senior Notes, together with accrued and unpaid interest, if any, to the date of redemption. We may redeem the 2010 Senior Notes in whole or in part at any time on or after the 12-month period beginning April 1, 2014 at a redemption price of 104.125% of the principal amount thereof, at a redemption price of 102.063% of the principal amount thereof if the redemption occurs during the 12-month period beginning on April 1, 2015, and at a redemption price of 100% of the principal amount thereof if the redemption occurs on and after April 1, 2016, in each case, plus accrued and unpaid interest, if any, to the redemption date. In addition, prior to April 1, 2013, with the net cash proceeds from certain equity offerings, we may redeem up to 35% in aggregate principal amount of the 2010 Senior Notes at a redemption price of 108.250% of the principal amount of the 2010 Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to the redemption date.

At any time prior to February 1, 2016, we may redeem the 2012 Senior Notes in whole or in part at a redemption price equal to 100% of the principal amount of the notes redeemed, plus a "make-whole premium" calculated as set forth in the indenture governing the 2012 Senior Notes, together with accrued and unpaid interest, if any, to the date of redemption. On or after February 1, 2016, we may redeem the 2012 Senior Notes in whole or in part at redemption prices set forth in the indenture governing the 2012 Senior Notes. In addition, at any time prior to February 1, 2015, we may redeem up to 35% of the aggregate principal amount of the 2012 Senior Notes at a redemption price equal to 108.125% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of certain equity offerings, provided that certain conditions are met. Subject to certain limitations, in the event of a change of control, as defined in the indenture governing the 2012 Senior Notes, Prestige Brands, Inc. will be required to make an offer to purchase the 2012 Senior Notes at a price equal to 101% of the aggregate principal amount of the 2012 Senior Notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.

The indentures governing the 2010 Senior Notes and 2012 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates. Additionally, the credit agreement with respect to the 2012 Term Loan and the 2012 ABL Revolver and the indenture governing the 2012 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement and the indenture governing the 2012 Senior Notes. At December 31, 2012, we were in compliance with the covenants under our long-term indebtedness.

During the nine months ended December 31, 2012, we made principal payments of $167.5 million against the outstanding 2012 Term Loan and borrowed a net amount of $40.0 million against the 2012 ABL Revolver.

Long-term debt consists of the following, as of the dates indicated:



(In thousands, except percentages)	December 31, 2012			March 31, 2012
2012 Senior Notes bearing interest at 8.125%, with interest only payable on February 1 and August 1 of each year. The 2012 Senior Notes mature on February 1, 2020.	$	250,000		$	250,000
2012 Term Loan bearing interest at the Company's option at either a base rate plus applicable margin with a floor of 2.25% or LIBOR with a floor of 1.25%, due on January 31, 2019.	467,500			635,000
2012 ABL Revolver bearing interest at the Company's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 31, 2017.	40,000			—
2010 Senior Notes bearing interest at 8.25%, with interest only payable on April 1 and October 1 of each year. The 2010 Senior Notes mature on April 1, 2018.	250,000			250,000
	1,007,500			1,135,000
Current portion of long-term debt	—			—
	1,007,500			1,135,000
Less: unamortized discount	(7,200		)	(11,092		)
Long-term debt, net of unamortized discount	$	1,000,300		$	1,123,908

During the three months ended December 31, 2012, we made significant payments toward our outstanding indebtedness under our 2012 Term Loan. As such, we accelerated the amortization of a portion of the debt discount related to the 2012 Term Loan in the amount of $2.6 million. Aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, the 2012 ABL Revolver and the indentures governing the 2010 Senior Notes and the 2012 Senior Notes are as follows:



(In thousands)
Year Ending March 31,	Amount
2013 (remaining three months ending March 31, 2013)	$	—
2014	—
2015	—
2016	—
2017	40,000
Thereafter	967,500
	$	1,007,500

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Dec. 31, 2012
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts. The Fair Value Measurements and Disclosures topic of the FASB ASC requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created: Level 1 - Quoted market prices for identical instruments in active markets; Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant. The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2012 Term Loan, the 2012 Senior Notes, the 2010 Senior Notes and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy. At December 31, 2012 and March 31, 2012, we did not have any assets or liabilities measured in Level 1 or 3. During any of the periods presented, there were no transfers of assets or liabilities between Levels 1, 2 and 3. At December 31, 2012 and March 31, 2012, the carrying value of our 2012 Senior Notes was $250.0 million and $250.0 million, respectively. The market value of our 2012 Senior Notes was $278.1 million and $270.6 million, respectively, at December 31, 2012 and March 31, 2012. At December 31, 2012 and March 31, 2012, the carrying value of the 2012 Term Loan was $467.5 million and $635.0 million, respectively. The market value of the 2012 Term Loan was $472.2 million and $639.0 million, respectively, at December 31, 2012 and March 31, 2012. At December 31, 2012 and March 31, 2012, the carrying value of our 2010 Senior Notes was $250.0 million and $250.0 million, respectively. The market value of our 2010 Senior Notes was $276.3 million and $272.5 million at December 31, 2012 and March 31, 2012, respectively. At December 31, 2012, the carrying value and the market value of the 2012 ABL Revolver was $40.0 million and $40.0 million, respectively.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 3, 10, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15C, 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32, 33, 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44A, 44B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13504-108611

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15B

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 17-22, 27, 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-Subparagraph a-d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Stockholders' Equity	9 Months Ended
Stockholders' Equity	Dec. 31, 2012
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid on the Company's common stock through December 31, 2012. Pursuant to the provisions of the various employee restricted stock awards, we repurchased no shares of restricted common stock from our employees during the three and nine months ended December 31, 2012. During the three and nine months ended December 31, 2011, we repurchased zero and 20,999 shares, respectively, of restricted common stock from our employees pursuant to the provisions of the various employee restricted stock awards. The repurchases were at an average price of $12.86. All of the repurchased shares have been recorded as treasury stock.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 7, 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

+ Details

Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Dec. 31, 2012

Accumulated Other Comprehensive Income [Abstract]

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) (“AOCI”) is comprised of various items that affect equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners.

AOCI consisted of the following at December 31, 2012 and March 31, 2012:



	December 31,		March 31,
(In thousands)	2012		2012
Components of Accumulated Other Comprehensive Income (Loss)
Cumulative translation adjustment	$	10	$	(13	)
Total accumulated other comprehensive loss	$	10	$	(13	)

Earnings Per Share

9 Months Ended

Dec. 31, 2012

Earnings Per Share [Abstract]

Earnings Per Share

Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based on the weighted-average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options, restricted stock awards and restricted stock units. The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended December 31,				Nine Months Ended December 31,
(In thousands, except per share data)	2012		2011		2012		2011
Numerator
Net income	$	12,257	$	9,510	$	46,156	$	37,227

Denominator
Denominator for basic earnings per share — weighted average shares outstanding	50,686		50,307		50,465		50,256
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors	837		377		820		411
Denominator for diluted earnings per share	51,523		50,684		51,285		50,667

Earnings per Common Share:
Basic net earnings per share	$	0.24	$	0.19	$	0.91	$	0.74

Diluted net earnings per share	$	0.24	$	0.19	$	0.90	$	0.73

For each of the three and nine months ended December 31, 2012, there were less than 0.1 million shares attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. For the three and nine months ended December 31, 2011, there were 0.7 million and 0.5 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.

- Definition

The entire disclosure for earnings per share.

+ References+ Details

Share-Based Compensation

9 Months Ended

Dec. 31, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation

Share-Based Compensation

In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the “Plan”), which provides for the grant of up to a maximum of 5.0 million shares of restricted stock, stock options, restricted stock units and other equity-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan.

During the three and nine months ended December 31, 2012, pre-tax share-based compensation costs charged against income were $1.0 million and $3.0 million, respectively, and the related income tax benefit recognized was $0.3 million and $0.9 million, respectively. During the three and nine months ended December 31, 2011, pre-tax share-based compensation costs charged against income were $0.7 million and $2.4 million, respectively, and the related income tax benefit recognized was $0.2 million and $0.6 million, respectively.

Restricted Shares

Restricted shares granted to employees under the Plan generally vest in 3 to 5 years, primarily upon the attainment of certain time vesting thresholds, and may also be contingent on the attainment of certain performance goals by the Company, including revenue and earnings before income taxes, depreciation and amortization targets. The restricted share awards provide for accelerated vesting if there is a change of control, as defined in the Plan. On May 9, 2012, the Compensation Committee of our Board of Directors granted 111,152 shares of restricted common stock units to certain executive officers and employees under the Plan. On June 29, 2012, the Compensation Committee of our Board of Directors granted 12,652 shares of restricted common stock units to the independent members of the Board of Directors under the Plan. On August 6, 2012, the Compensation Committee of the Board of Directors granted 5,109 shares of restricted common stock units to Matthew M. Mannelly.

The restricted common stock units granted to Directors will vest in their entirety one year after the date of grant so long as the membership on the Board of Directors continues through the vesting date, with the settlement in common stock to occur on the earliest of the director's death, disability or six month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. The restricted common stock units granted to employees generally vest in their entirety on the 3-year anniversary of the date of the grant. Upon vesting, the units will be settled in shares of our common stock. The fair value of the restricted common stock units is determined using the closing price of our common stock on the day of grant. The weighted-average grant-date fair value of restricted shares granted during the nine months ended December 31, 2012 and 2011 was $13.59 and $11.35, respectively.

A summary of the Company's restricted shares granted under the Plan is presented below:



Restricted Shares	Shares (in thousands)		Weighted- Average Grant-Date Fair Value
Nine months ended December 31, 2011:
Outstanding at March 31, 2011	275.4		$	8.46
Granted	122.5		11.35
Vested and issued	(103.4	)	9.93
Forfeited	(15.2	)	10.72
Outstanding at December 31, 2011	279.3		9.06
Vested at December 31, 2011	54.0		7.40

Nine months ended December 31, 2012:
Outstanding at March 31, 2012	363.4		$	9.92
Granted	128.9		13.59
Vested and issued	(27.0	)	7.16
Forfeited	(12.3	)	10.69
Outstanding at December 31, 2012	453.0		11.11
Vested at December 31, 2012	70.4		8.52

Options

The Plan provides that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted. Options granted have a term of no greater than 10 years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally 3 to 5 years. The option awards provide for accelerated vesting if there is a change in control, as defined in the Plan.

The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below. Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies. We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the options granted are derived from management's estimates and consideration of information derived from the public filings of companies similar to us and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted option. On May 9, 2012, the Compensation Committee of our Board of Directors granted stock options to acquire 422,962 shares of our common stock to certain executive officers and employees under the Plan. These stock options were granted at an exercise price of $13.24 per share, which is equal to the closing price for our common stock on the day of the grant. On August 6, 2012, the Compensation Committee of the Board of Directors granted stock options to acquire 21,978 shares of our common stock to Matthew M. Mannelly. These stock options were granted at an exercise price of $15.66 per share, which is equal to the closing price for our common stock on the date of grant. The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant.

The weighted-average grant-date fair value of the options granted during the nine months ended December 31, 2012 and 2011 was $6.03 and $5.83, respectively.



	Nine Months Ended December 31,
	2012			2011
Expected volatility	44.0		%	53.0		%
Expected dividends	$	—		$	—
Expected term in years	6.5			6.5
Risk-free rate	1.2		%	2.4		%

A summary of option activity under the Plan is as follows:



Options	Shares (in thousands)		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)
Nine months ended December 31, 2011:
Outstanding at March 31, 2011	1,621.5		$	8.19
Granted	308.1		11.27
Exercised	(54.2	)	10.54
Forfeited or expired	(78.9	)	11.93
Outstanding at December 31, 2011	1,796.5		8.48		7.9	$	5,125
Exercisable at December 31, 2011	678.0		8.43		7.4	2,035

Nine months ended December 31, 2012:
Outstanding at March 31, 2012	1,745.4		$	8.44
Granted	444.9		13.36
Exercised	(708.5	)	7.71
Forfeited or expired	(17.4	)	11.21
Outstanding at December 31, 2012	1,464.4		10.26		7.7	$	11,330
Exercisable at December 31, 2012	332.4		9.99		6.8	2,248

The aggregate intrinsic value of options exercised in the nine months ended December 31, 2012 was $8.8 million. The aggregate intrinsic value at December 31, 2012 for options granted during the nine months ended December 31, 2012 was $3.0 million.

At December 31, 2012, there were $4.0 million of unrecognized compensation costs related to nonvested share-based compensation arrangements under the Plan, based on management's estimate of the shares that will ultimately vest. We expect to recognize such costs over a weighted-average period of 0.9 years. The total fair value of options and restricted shares vested during the nine months ended December 31, 2012 and 2011 was $2.1 million and $2.8 million, respectively. For the nine months ended December 31, 2012 and 2011, cash received from the exercise of stock options was $5.4 million and $0.7 million, respectively, and we realized $9.3 million and $0.1 million, respectively, in tax benefits for the tax deductions resulting from these option exercises. At December 31, 2012, there were 1.9 million shares available for issuance under the Plan.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Income Taxes	9 Months Ended
Income Taxes	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur. The effective tax rate used in the calculation of income taxes was 38.9% and 38.7%, respectively, for the three months ended December 31, 2012 and December 31, 2011. The effective tax rate used in the calculation of income taxes was 38.9% and 38.3%, respectively, for the nine months ended December 31, 2012 and December 31, 2011. The increase in the effective tax rate for both the three and nine months ended December 31, 2012 is primarily due to higher state income taxes and non-deductible compensation. At December 31, 2012, a wholly-owned subsidiary had a net operating loss carryforward of approximately $1.2 million, which may be used to offset future taxable income of the consolidated group and which begins to expire in 2020. The net operating loss carryforward is subject to an annual limitation as to usage of approximately $0.2 million pursuant to Internal Revenue Code Section 382. We experienced a small reduction in our uncertain tax liability during the nine months ended December 31, 2012. Therefore, the balance in our uncertain tax liability was $0.2 million at December 31, 2012 and $0.3 million at March 31, 2012. We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. We did not incur any material interest or penalties related to income taxes in any of the periods presented.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Commitments and Contingencies

9 Months Ended

Dec. 31, 2012

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

We are involved from time to time in routine legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, cash flows or results from operations.

Lease Commitments

We have operating leases for office facilities and equipment in New York and Wyoming, which expire at various dates through 2018. Due to the recent acquisition of the GSK Brands, we required additional office space and entered into a 5.5 year lease for a new office facility in New York, which began in the third quarter of fiscal 2013. In May 2012, we also entered into a 3 year office lease in Rogers, Arkansas. These amounts have been included in the schedule below.

The following summarizes future minimum lease payments for our operating leases as of December 31, 2012:



(In thousands)
Year Ending March 31,	Facilities		Equipment		Total
2013 (Remaining three months ending March 31, 2013)	$	275	$	36	$	311
2014	1,764		141		1,905
2015	1,049		136		1,185
2016	994		135		1,129
2017	1,023		68		1,091
Thereafter	1,044		—		1,044
	$	6,149	$	516	$	6,665

Rent expense for the three months ended December 31, 2012 and 2011 was $0.3 million and $0.2 million, respectively, while rent expense for the nine months ended December 31, 2012 and 2011 was $0.9 million and $0.7 million, respectively.

Purchase Commitments

Effective November 1, 2009, we entered into a 10 year supply agreement for the exclusive manufacture of a portion of one of our Household Cleaning products. Although we are committed under the supply agreement to pay the minimum amounts set forth in the table below, the total commitment is less than ten percent of the estimated purchases that we expect to make during the course of the agreement. Additionally, we entered into a short-term supply arrangement with one of our Canadian suppliers to provide a certain amount of product through January 2013. As such, we have included $3.2 million of purchase commitments in the remaining three months ended March 31, 2013.



(In thousands)
Year Ending March 31,	Amount
2013 (Remaining three months ending March 31, 2013)	$	3,460
2014	1,136
2015	1,105
2016	1,074
2017	1,044
Thereafter	2,555
	$	10,374

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Concentrations of Risk	9 Months Ended
Concentrations of Risk	Dec. 31, 2012
Risks and Uncertainties [Abstract]
Concentrations of Risk	Concentrations of Risk Our revenues are concentrated in the areas of OTC Healthcare and Household Cleaning products. We sell our products to mass merchandisers, food and drug stores, and dollar and club stores. During the three and nine months ended December 31, 2012, approximately 40.3% and 40.7%, respectively, of our total revenues were derived from our five top selling brands. During the three and nine months ended December 31, 2011, approximately 55.0% and 54.8%, respectively, of our total revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented. Such customer accounted for approximately 15.3% and 16.6%, respectively, of our gross revenues for the three and nine months ended December 31, 2012, and approximately 20.9% and 19.1%, respectively, of our gross revenues for the three and nine months ended December 31, 2011. At December 31, 2012, approximately 23.6% of accounts receivable were owed by the same customer. We manage product distribution in the continental United States through a third-party distribution center in St. Louis, Missouri. A serious disruption, such as a flood or fire, to the main distribution center could damage our inventories and could materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost. We could incur significantly higher costs and experience longer lead times associated with the distribution of our products to our customers during the time that it takes us to reopen or replace our distribution center. As a result, any such disruption could have a material adverse effect on our business, sales and profitability. At December 31, 2012, we had relationships with 62 third-party manufacturers. Of those, we had long-term contracts with 24 manufacturers that produced items that accounted for approximately 77.1% of gross sales for the nine months ended December 31, 2012. At December 31, 2011, we had relationships with 52 third-party manufacturers. Of those, we had long-term contracts with 15 manufacturers that produced items that accounted for approximately 66.7% of gross sales for the nine months ended December 31, 2011. The fact that we do not have long-term contracts with certain manufacturers means they could cease producing products at any time and for any reason, or initiate arbitrary and costly price increases, which could have a material adverse effect on our business, financial condition, cash flows and results from operations.

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 21, 22, 24

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592

+ Details

Business Segments

9 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Business Segments

Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC. Our current operating and reportable segments consist of (i) OTC Healthcare and (ii) Household Cleaning. There were no inter-segment sales or transfers during any of the periods presented. We evaluate the performance of our operating segments and allocate resources to them based primarily on contribution margin.

The tables below summarize information about our operating and reportable segments.



	Three Months Ended December 31, 2012						Nine Months Ended December 31, 2012
(In thousands)	OTC Healthcare		Household Cleaning		Consolidated		OTC Healthcare		Household Cleaning		Consolidated
Net sales	$	138,858	$	20,634	$	159,492	$	402,633	$	64,102	$	466,735
Other revenues	175		565		740		520		1,829		2,349
Total revenues	139,033		21,199		160,232		403,153		65,931		469,084
Cost of sales	59,381		15,854		75,235		160,249		49,689		209,938
Gross profit	79,652		5,345		84,997		242,904		16,242		259,146
Advertising and promotion	22,410		1,128		23,538		62,309		5,062		67,371
Contribution margin	$	57,242	$	4,217	61,459		$	180,595	$	11,180	191,775
Other operating expenses					14,737						50,064
Operating income					46,722						141,711
Other expense					26,661						66,169
Income before income taxes					20,061						75,542
Provision for income taxes					7,804						29,386
Net income					$	12,257					$	46,156



	Three Months Ended December 31, 2011						Nine Months Ended December 31, 2011
(In thousands)	OTC Healthcare		Household Cleaning		Consolidated		OTC Healthcare		Household Cleaning		Consolidated
Net sales	$	84,711	$	21,088	$	105,799	$	234,712	$	69,966	$	304,678
Other revenues	195		256		451		552		1,859		2,411
Total revenues	84,906		21,344		106,250		235,264		71,825		307,089
Cost of sales	35,329		15,799		51,128		97,198		50,995		148,193
Gross profit	49,577		5,545		55,122		138,066		20,830		158,896
Advertising and promotion	14,170		1,104		15,274		34,746		3,834		38,580
Contribution margin	$	35,407	$	4,441	39,848		$	103,320	$	16,996	120,316
Other operating expenses					16,218						40,049
Operating income					23,630						80,267
Other expense					8,116						19,910
Income before income taxes					15,514						60,357
Provision for income taxes					6,004						23,130
Net income					$	9,510					$	37,227

The table below summarizes information about our revenues from similar product groups.



	Three Months Ended December 31,		Nine Months Ended December 31,
(In thousands)	2012	2011	2012	2011
Analgesics	27,946	597	81,727	1,955
Cough & Cold	37,424	40,621	94,197	89,858
Gastrointestinal	24,977	3,480	74,510	13,924
Eye & Ear Care	19,702	17,091	63,109	53,940
Dermatologicals	11,496	10,580	41,578	39,060
Oral Care	12,953	11,501	36,032	33,712
Other OTC	4,535	1,036	12,000	2,815
Total OTC Healthcare Segment	139,033	84,906	403,153	235,264
Household Cleaning Segment	21,199	21,344	65,931	71,825
Consolidated Total Revenues	160,232	106,250	469,084	307,089

During the three and nine months ended December 31, 2012, approximately 97.2% and 97.4%, respectively, of our sales were made to customers in the United States and Canada, while during the three and nine months ended December 31, 2011, approximately 96.2% and 96.3%, respectively, of our sales were made to customers in the United States and Canada. Other than the United States, no individual geographical area accounted for more than 10% of net sales in any of the periods presented.

At December 31, 2012, substantially all of our long-term assets were located in the United States and have been allocated to the operating segments as follows:



(In thousands)	OTC Healthcare		Household Cleaning		Consolidated
Goodwill	$	160,157	$	7,389	$	167,546

Intangible assets
Indefinite-lived	1,125,594		119,820		1,245,414
Finite-lived	102,177		28,347		130,524
	1,227,771		148,167		1,375,938

	$	1,387,928	$	155,556	$	1,543,484

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

+ Details

Gain on Settlement	9 Months Ended
Gain on Settlement	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Gain on Settlement	Gain on Settlement On June 15, 2011, we received a settlement payment of $8.0 million in the resolution of pending litigation, which Prestige Brands, Inc. had initiated for legal malpractice, breach of contract and breach of fiduciary duty against a law firm and two individual lawyers who had previously provided legal representation to Prestige Brands, Inc. Because the result of the litigation could only have resulted in a potential gain and the amount could not be determined prior to the settlement, the settlement payment was not disclosed prior to the actual receipt of the settlement. Additionally, the costs netted against the gain during the period ended June 30, 2011 were legal fees paid solely on a contingent basis and other immaterial legal fees incurred in the period ended June 30, 2011. All other costs and legal fees that were incurred prior to the period ended June 30, 2011 were immaterial and expensed as incurred. We incurred costs of $2.9 million in pursuing this matter. Therefore, we recorded a pre-tax gain on settlement of $5.1 million net of costs incurred and $3.2 million after income tax effects for the nine months ended December 31, 2011. The $5.1 million pre-tax gain is included in other (income) expense, as this gain did not relate to our ongoing operations.

Condensed Consolidating Financial Statements

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Financial Statements

As described in Note 10, Prestige Brands Holdings, Inc., together with certain of our wholly-owned subsidiaries, have fully and unconditionally guaranteed, on a joint and several basis, the obligations of Prestige Brands, Inc. (a wholly-owned subsidiary of the Company) set forth in the indentures governing the 2012 Senior Notes and the 2010 Senior Notes, including, without limitation, the obligation to pay principal and interest with respect to the 2012 Senior Notes and the 2010 Senior Notes. The wholly-owned subsidiaries of the Company that have guaranteed the 2012 Senior Notes and the 2010 Senior Notes are as follows: Prestige Personal Care Holdings, Inc., Prestige Personal Care, Inc., Prestige Services Corp., Prestige Brands Holdings, Inc. (a Virginia corporation), Prestige Brands International, Inc., Medtech Holdings, Inc., Medtech Products Inc., The Cutex Company, The Denorex Company, The Spic and Span Company, and Blacksmith Brands, Inc. (collectively, the "Subsidiary Guarantors"). A significant portion of our operating income and cash flow is generated by our subsidiaries. As a result, funds necessary to meet Prestige Brands, Inc.'s debt service obligations are provided in part by distributions or advances from our subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of our subsidiaries, could limit Prestige Brands, Inc.'s ability to obtain cash from our subsidiaries for the purpose of meeting our debt service obligations, including the payment of principal and interest on the 2012 Senior Notes and the 2010 Senior Notes. Although holders of the 2012 Senior Notes and the 2010 Senior Notes will be direct creditors of the guarantors of the 2012 Senior Notes and the 2010 Senior Notes by virtue of the guarantees, we have indirect subsidiaries located primarily in the United Kingdom and in the Netherlands (collectively, the "Non-Guarantor Subsidiaries") that have not guaranteed the 2012 Senior Notes or the 2010 Senior Notes, and such subsidiaries will not be obligated with respect to the 2012 Senior Notes or the 2010 Senior Notes. As a result, the claims of creditors of the Non-Guarantor Subsidiaries will effectively have priority with respect to the assets and earnings of such companies over the claims of the holders of the 2012 Senior Notes and the 2010 Senior Notes.

Presented below are supplemental Condensed Consolidating Balance Sheets as of December 31, 2012 and March 31, 2012, Condensed Consolidating Income and Comprehensive Income Statements for the three and nine months ended December 31, 2012 and 2011, and Condensed Consolidating Statements of Cash Flows for the nine months ended December 31, 2012 and 2011. Such consolidating information includes separate columns for:

a) Prestige Brands Holdings, Inc., the parent,

b) Prestige Brands, Inc., the issuer,

c) Combined Subsidiary Guarantors,

d) Combined Non-Guarantor Subsidiaries, and

e) Elimination entries necessary to consolidate the Company and all of its subsidiaries.

The Condensed Consolidating Financial Statements are presented using the equity method of accounting for investments in wholly-owned subsidiaries. Under the equity method, the investments in subsidiaries are recorded at cost and adjusted for our share of the subsidiaries' cumulative results of operations, capital contributions, distributions and other equity changes. The elimination entries principally eliminate investments in subsidiaries and intercompany balances and transactions. The financial information in this note should be read in conjunction with the Consolidated Financial Statements presented and other notes related thereto contained in this Quarterly Report on Form 10-Q.

Condensed Consolidating Statements of Income and Comprehensive Income

Three Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	25,345		$	132,881		$	1,266		$	—		$	159,492
Other revenues	—			79			724			276			(339		)	740
Total revenues	—			25,424			133,605			1,542			(339		)	160,232

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			9,877			65,172			525			(339		)	75,235
Gross profit	—			15,547			68,433			1,017			—			84,997

Operating Expenses
Advertising and promotion	—			3,032			19,997			509			—			23,538
General and administrative	952			1,585			8,734			107			—			11,378
Depreciation and amortization	549			140			2,658			12			—			3,359
Total operating expenses	1,501			4,757			31,389			628			—			38,275
Operating income (loss)	(1,501		)	10,790			37,044			389			—			46,722

Other (income) expense
Interest income	33			(41,552		)	162			(62		)	41,415			(4		)
Interest expense	8,735			35,394			23,951			—			(41,415		)	26,665
Equity in income of subsidiaries	(18,531		)	(8,407		)	(393		)	—			27,331			—
Total other (income) expense	(9,763		)	(14,565		)	23,720			(62		)	27,331			26,661
Income before income taxes	8,262			25,355			13,324			451			(27,331		)	20,061
Provision (benefit) for income taxes	(3,995		)	6,593			5,030			176			—			7,804
Net income (loss)	$	12,257		$	18,762		$	8,294		$	275		$	(27,331	)	$	12,257

Comprehensive income, net of tax:
Currency translation adjustments	(1		)	—			—			1			(1		)	(1		)
Total other comprehensive income (loss)	(1		)	—			—			1			(1		)	(1		)
Comprehensive income (loss)	$	12,256		$	18,762		$	8,294		$	276		$	(27,332	)	$	12,256

Condensed Consolidating Statements of Income and Comprehensive Income

Nine Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	75,294		$	387,815		$	3,626		$	—		$	466,735
Other revenues	—			220			2,310			1,270			(1,451		)	2,349
Total revenues	—			75,514			390,125			4,896			(1,451		)	469,084

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			28,493			181,382			1,514			(1,451		)	209,938
Gross profit	—			47,021			208,743			3,382			—			259,146

Operating Expenses
Advertising and promotion	—			8,917			57,326			1,128			—			67,371
General and administrative	3,676			5,020			30,802			616			—			40,114
Depreciation and amortization	818			420			8,667			45			—			9,950
Total operating expenses	4,494			14,357			96,795			1,789			—			117,435
Operating income (loss)	(4,494		)	32,664			111,948			1,593			—			141,711

Other (income) expense
Interest income	(24,337		)	(63,573		)	162			(163		)	87,902			(9		)
Interest expense	26,147			92,320			35,613			—			(87,902		)	66,178
Equity in income of subsidiaries	(50,008		)	(49,280		)	(1,306		)	—			100,594			—
Total other (income) expense	(48,198		)	(20,533		)	34,469			(163		)	100,594			66,169
Income before income taxes	43,704			53,197			77,479			1,756			(100,594		)	75,542
Provision (benefit) for income taxes	(2,452		)	1,524			29,631			683			—			29,386
Net income (loss)	$	46,156		$	51,673		$	47,848		$	1,073		$	(100,594	)	$	46,156

Comprehensive income, net of tax:
Currency translation adjustments	23			—			—			(23		)	23			23
Total other comprehensive income (loss)	23			—			—			(23		)	23			23
Comprehensive income (loss)	$	46,179		$	51,673		$	47,848		$	1,050		$	(100,571	)	$	46,179

Condensed Consolidating Statements of Income and Comprehensive Income

Three Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	27,352		$	77,308	$	1,139		$	—		$	105,799
Other revenues	—			57			451		227			(284		)	451
Total revenues	—			27,409			77,759		1,366			(284		)	106,250

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			9,784			41,154		474			(284		)	51,128
Gross profit	—			17,625			36,605		892			—			55,122

Operating Expenses
Advertising and promotion	3			3,431			11,216		624			—			15,274
General and administrative	5,318			2,322			5,684		331			—			13,655
Depreciation and amortization	135			143			2,267		18			—			2,563
Total operating expenses	5,456			5,896			19,167		973			—			31,492
Operating income (loss)	(5,456		)	11,729			17,438		(81		)	—			23,630

Other (income) expense
Interest income	(12,302		)	(11,118		)	—		(60		)	23,479			(1		)
Interest expense	8,791			16,907			5,898		—			(23,479		)	8,117
Equity in income of subsidiaries	(10,727		)	(7,936		)	39		—			18,624			—
Total other (income) expense	(14,238		)	(2,147		)	5,937		(60		)	18,624			8,116
Income (loss) before income taxes	8,782			13,876			11,501		(21		)	(18,624		)	15,514
Provision (benefit) for income taxes	(728		)	2,285			4,454		(7		)	—			6,004
Net income (loss)	9,510			11,591			7,047		(14		)	(18,624		)	9,510

Comprehensive income, net of tax:
Currency translation adjustments	(18		)	—			—		(18		)	18			(18		)
Total other comprehensive income (loss)	(18		)	—			—		(18		)	18			(18		)
Comprehensive income (loss)	$	9,492		$	11,591		$	7,047	$	(32	)	$	(18,606	)	$	9,492

Condensed Consolidating Statements of Income and Comprehensive Income

Nine Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	74,767		$	226,859		$	3,052		$	—		$	304,678
Other revenues	—			178			2,386			1,131			(1,284		)	2,411
Total revenues	—			74,945			229,245			4,183			(1,284		)	307,089

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			27,191			121,032			1,254			(1,284		)	148,193
Gross profit	—			47,754			108,213			2,929			—			158,896

Operating Expenses
Advertising and promotion	3			9,341			28,133			1,103			—			38,580
General and administrative	5,514			7,502			18,538			812			—			32,366
Depreciation and amortization	412			428			6,789			54			—			7,683
Total operating expenses	5,929			17,271			53,460			1,969			—			78,629
Operating income (loss)	(5,929		)	30,483			54,753			960			—			80,267

Other (income) expense
Interest income	(38,196		)	(33,291		)	—			(173		)	71,656			(4		)
Interest expense	26,323			51,299			19,011			—			(71,656		)	24,977
Gain on settlement	(5,063		)	—			—			—			—			(5,063		)
Equity in income of subsidiaries	(30,438		)	(23,768		)	(745		)	—			54,951			—
Total other (income) expense	(47,374		)	(5,760		)	18,266			(173		)	54,951			19,910
Income (loss) before income taxes	41,445			36,243			36,487			1,133			(54,951		)	60,357
Provision (benefit) for income taxes	4,218			4,781			13,697			434			—			23,130
Net income (loss)	37,227			31,462			22,790			699			(54,951		)	37,227

Comprehensive income, net of tax:
Currency translation adjustments	(70		)	—			—			(70		)	70			(70		)
Total other comprehensive income (loss)	(70		)	—			—			(70		)	70			(70		)
Comprehensive income (loss)	$	37,157		$	31,462		$	22,790		$	629		$	(54,881	)	$	37,157

Condensed Consolidating Balance Sheet

December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	8,878		$	—		$	—	$	1,553	$	—		$	10,431
Accounts receivable, net	140			13,217			59,428		967		—			73,752
Inventories	—			9,340			44,218		692		—			54,250
Deferred income tax assets	213			730			5,651		—		—			6,594
Prepaid expenses and other current assets	1,656			425			4,101		13		—			6,195
Total current assets	10,887			23,712			113,398		3,225		—			151,222

Property and equipment, net	8,987			25			178		—		—			9,190
Goodwill	—			66,007			101,539		—		—			167,546
Intangible assets, net	—			193,530			1,182,074		334		—			1,375,938
Other long-term assets	—			27,493			—		—		—			27,493
Intercompany receivable	1,284,415			1,933,896			420,375		7,537		(3,646,223		)	—
Investment in subsidiary	808,377			622,107			6,890		—		(1,437,374		)	—
Total Assets	$	2,112,666		$	2,866,770		$	1,824,454	$	11,096	$	(5,083,597	)	$	1,731,389

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	2,275		$	7,304		$	30,012	$	1,267	$	—		$	40,858
Accrued interest payable	—			13,620			—		—		—			13,620
Other accrued liabilities	10,571			2,485			19,958		1,258		—			34,272
Total current liabilities	12,846			23,409			49,970		2,525		—			88,750

Long-term debt
Principal amount	—			1,007,500			—		—		—			1,007,500
Less unamortized discount	—			(7,200		)	—		—		—			(7,200		)
Long-term debt, net of unamortized discount	—			1,000,300			—		—		—			1,000,300

Deferred income tax liabilities	—			50,869			134,059		79		—			185,007
Intercompany payable	1,642,488			451,454			1,552,100		181		(3,646,223		)	—
Total Liabilities	1,655,334			1,526,032			1,736,129		2,785		(3,646,223		)	1,274,057

Stockholders' Equity
Preferred share rights	283			—			—		—		—			283
Common stock	512			—			—		—		—			512
Additional paid-in capital	400,316			1,280,945			39,724		1,111		(1,321,780		)	400,316
Treasury stock, at cost - 181 shares	(687		)	—			—		—		—			(687		)
Accumulated other comprehensive income, net of tax	10			—			—		10		(10		)	10
Retained earnings (accumulated deficit)	56,898			59,793			48,601		7,190		(115,584		)	56,898
Total Stockholders' Equity	457,332			1,340,738			88,325		8,311		(1,437,374		)	457,332
Total Liabilities and Stockholders' Equity	$	2,112,666		$	2,866,770		$	1,824,454	$	11,096	$	(5,083,597	)	$	1,731,389

Condensed Consolidating Balance Sheet

March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	18,221		$	—		$	—	$	794		$	—		$	19,015
Accounts receivable, net	25			13,502			45,954		747			—			60,228
Inventories	—			8,098			42,334		681			—			51,113
Deferred income tax assets	356			849			4,078		—			—			5,283
Prepaid expenses and other current assets	8,102			56			2,874		364			—			11,396
Total current assets	26,704			22,505			95,240		2,586			—			147,035

Property and equipment, net	934			22			346		2			—			1,304
Goodwill	—			66,007			107,695		—			—			173,702
Intangible assets, net	—			193,932			1,206,213		377			—			1,400,522
Other long-term assets	—			35,713			—		—			—			35,713
Intercompany receivable	680,067			1,449,005			314,699		5,935			(2,449,706		)	—
Investment in subsidiary	1,358,120			1,172,601			5,583		—			(2,536,304		)	—
Total Assets	$	2,065,825		$	2,939,785		$	1,729,776	$	8,900		$	(4,986,010	)	$	1,758,276

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	4,531		$	4,816		$	17,008	$	371		$	—		$	26,726
Accrued interest payable	—			13,889			—		—			—			13,889
Other accrued liabilities	11,758			1,687			8,944		919			—			23,308
Total current liabilities	16,289			20,392			25,952		1,290			—			63,923

Long-term debt
Principal amount	—			1,135,000			—		—			—			1,135,000
Less unamortized discount	—			(11,092		)	—		—			—			(11,092		)
Long-term debt, net of unamortized discount	—			1,123,908			—		—			—			1,123,908

Deferred income tax liabilities	—			50,944			116,690		83			—			167,717
Intercompany payable	1,646,808			455,702			346,884		312			(2,449,706		)	—
Total Liabilities	1,663,097			1,650,946			489,526		1,685			(2,449,706		)	1,355,548

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common stock	505			—			—		—			—			505
Additional paid-in capital	391,898			1,280,719			1,239,497		1,111			(2,521,327		)	391,898
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(13		)	—			—		(13		)	13			(13		)
Retained earnings (accumulated deficit)	10,742			8,120			753		6,117			(14,990		)	10,742
Total Stockholders' Equity	402,728			1,288,839			1,240,250		7,215			(2,536,304		)	402,728
Total Liabilities and Stockholders' Equity	$	2,065,825		$	2,939,785		$	1,729,776	$	8,900		$	(4,986,010	)	$	1,758,276

Condensed Consolidating Statement of Cash Flows

Nine Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	46,156		$	51,673		$	47,848		$	1,073		$	(100,594	)	$	46,156
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	818			420			8,667			45			—			9,950
Deferred income taxes	143			44			15,796			(4		)	—			15,979
Amortization of deferred financing costs	—			8,220			—			—			—			8,220
Stock-based compensation costs	2,965			—			—			—			—			2,965
Amortization of debt discount	—			3,892			—			—			—			3,892
Lease termination costs	975			—			—			—			—			975
Loss on disposal of equipment	30			—			21			—			—			51
Equity in income of subsidiaries	(50,008		)	(49,280		)	(1,306		)	—			100,594			—
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(115		)	285			(13,474		)	(214		)	—			(13,518		)
Inventories	—			(1,242		)	(2,104		)	(5		)	—			(3,351		)
Prepaid expenses and other current assets	6,446			(369		)	(627		)	351			—			5,801
Accounts payable	(3,347		)	2,488			14,095			889			—			14,125
Accrued liabilities	(1,071		)	529			9,830			343			—			9,631
Net cash provided by operating activities	2,992			16,660			78,746			2,478			—			100,876

Investing Activities
Purchases of property and equipment	(8,922		)	—			—			—			—			(8,922		)
Proceeds from the sale of property and equipment	—			—			15			—			—			15
Proceeds from the sale of the Phazyme brand	—			—			21,700			—			—			21,700
Acquisition of brands from GSK purchase price adjustments	—			—			(226		)	—			—			(226		)
Intercompany activity, net	(226		)	—			226			—			—			—
Net cash provided by (used in) investing activities	(9,148		)	—			21,715			—			—			12,567

Financing Activities
Repayments of long-term debt	—			(167,500		)	—			—			—			(167,500		)
Repayments under revolving credit agreement	—			(8,000		)	—			—			—			(8,000		)
Borrowings under revolving credit agreement	—			48,000			—			—			—			48,000
Proceeds from exercise of stock options	5,460			—			—			—			—			5,460
Intercompany activity, net	(8,647		)	110,840			(100,461		)	(1,732		)	—			—
Net cash used in financing activities	(3,187		)	(16,660		)	(100,461		)	(1,732		)	—			(122,040		)

Effect of exchange rate changes on cash and cash equivalents	—			—			—			13			—			13
(Decrease) increase in cash and cash equivalents	(9,343		)	—			—			759			—			(8,584		)
Cash - beginning of period	18,221			—			—			794			—			19,015
Cash - end of period	$	8,878		$	—		$	—		$	1,553		$	—		$	10,431

Condensed Consolidating Statement of Cash Flows

Nine Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	37,227		$	31,462		$	22,790		$	699		$	(54,951	)	$	37,227
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	412			428			6,789			54			—			7,683
Deferred income taxes	427			1,612			5,293			(11		)	—			7,321
Amortization of deferred financing costs	—			847			—			—			—			847
Stock-based compensation costs	2,360			—			—			—			—			2,360
Amortization of debt discount	—			687			—			—			—			687
Equity in income of subsidiaries	(30,438		)	(23,768		)	(745		)	—			54,951			—
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(23		)	(2,930		)	(2,671		)	(192		)	—			(5,816		)
Inventories	—			(1,053		)	(2,822		)	25			—			(3,850		)
Prepaid expenses and other current assets	3,219			(138		)	(418		)	(13		)	—			2,650
Accounts payable	(31		)	(502		)	2,571			354			—			2,392
Accrued liabilities	589			(5,032		)	761			174			—			(3,508		)
Net cash provided by operating activities	13,742			1,613			31,548			1,090			—			47,993

Investing Activities
Purchases of property and equipment	(140		)	—			(218		)	—			—			(358		)
Proceeds from escrow of Blacksmith acquisition	—			—			1,200			—			—			1,200
Intercompany activity, net	1,200			—			(1,200		)	—			—			—
Net cash provided by (used in) investing activities	1,060			—			(218		)	—			—			842

Financing Activities
Repayment of long-term debt	—			(58,000		)	—			—			—			(58,000		)
Proceeds from exercise of stock options	572			—			—			—			—			572
Shares surrendered as payment of tax withholding	(271		)	—			—			—			—			(271		)
Intercompany activity, net	(24,256		)	56,387			(31,330		)	(801		)	—			—
Net cash used in financing activities	(23,955		)	(1,613		)	(31,330		)	(801		)	—			(57,699		)

Effect of exchange rate changes on cash and cash equivalents	—			—			—			(31		)	—			(31		)
Increase in cash and cash equivalents	(9,153		)	—			—			258			—			(8,895		)
Cash - beginning of period	12,698			—			—			636			—			13,334
Cash - end of period	$	3,545		$	—		$	—		$	894		$	—		$	4,439

In the first quarter of fiscal 2013, the Company determined that in prior periods it had incorrectly recorded intercompany transactions between Prestige Brands Holdings, Inc. ("the Parent") and Prestige Brands, Inc. ("the Issuer") as a component of interest expense, resulting in (i) the misclassification of amounts between interest expense, equity in income of subsidiaries, and taxes of the Parent, and (ii) a corresponding understatement of interest income, taxes and net income of the Issuer. It was further determined that certain subsidiaries of the Issuer had been fully consolidated by the Issuer in error, resulting in (i) a gross-up of the Issuer's balance sheet, statement of income and comprehensive income and statement of cash flows and (ii) the need to revise the presentation to reflect the Issuer's interests in those subsidiaries under the equity method. Those entities had previously been incorrectly included in the Issuer column and omitted from the Guarantor column, and accordingly, this resulted in a need to revise the presentation to include the balance sheet, results of operations, and cash flows of those Issuer subsidiary entities in the Combined Subsidiary Guarantors column of the revised condensed consolidating financial statements. In addition, the Company reclassified portions of its intercompany activity between operating and financing in the statement of cash flows. The Company also determined that it had incorrectly presented certain intercompany balances between the Parent, the Issuer, the Combined Subsidiary Guarantors and Non-Guarantors resulting in revisions impacting other accrued liabilities, deferred income taxes, provision (benefit) for income taxes, intercompany receivables, intercompany payables, investment in subsidiaries and total equity balances. Additionally, certain revisions have been made to the Company's Condensed Consolidating Statement of Income and Comprehensive Income for the three months ended June 30, 2012. For the three months ended June 30, 2012, the provision for income taxes was increased approximately $4.3 million to $0.6 million for the Parent, and the benefit for income taxes was increased approximately $4.4 million to $3.0 million for the Issuer.

The Company has revised its Condensed Consolidating Financial Statements to correct the presentation of these items. There were no changes to any of the Company's Condensed Consolidated Financial Statements. The Company assessed the materiality of these items on previously issued annual and interim financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108, and concluded that the revisions were not material to the consolidated financial statements. The Company will disclose the impact of the revisions on previously reported amounts and accordingly revise the Condensed Consolidated Financial Statements for comparative periods in its future filings. The impact of these revisions as of March 31, 2012 and for each of the three and nine month periods ended December 31, 2011 are shown in the following tables:

Condensed Consolidating Statement of Income and Comprehensive Income for the Three Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.					Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries						Eliminations
	Reported		Revised			Reported		Revised		Reported			Revised		Reported			Revised			Reported			Revised
Revenue	$	—	$	—		$	83,768	$	27,409	$	21,343		$	77,759	$	1,423		$	1,366		$	(284	)	$	(284	)
Income before income taxes	13,575		8,782			6,402		13,876		(1,316		)	11,501		(22		)	(21		)	(3,125		)	(18,624		)
Provision (benefit) for income taxes	4,065		(728		)	2,430		2,285		(509		)	4,454		18			(7		)	—			—
Net income	9,510		9,510			3,972		11,591		(807		)	7,047		(40		)	(14		)	(3,125		)	(18,624		)

Condensed Consolidating Statement of Income and Comprehensive Income for the Nine Months Ended December 31, 2011.



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	232,214	$	74,945	$	71,823		$	229,245	$	4,336	$	4,183	$	(1,284	)	$	(1,284	)
Income before income taxes	52,806		41,445		20,701		36,243		(2,163		)	36,487		1,132		1,133		(12,119		)	(54,951		)
Provision (benefit) for income taxes	15,579		4,218		8,000		4,781		(837		)	13,697		388		434		—			—
Net income	37,227		37,227		12,701		31,462		(1,326		)	22,790		744		699		(12,119		)	(54,951		)

Condensed Consolidating Balance sheet as of March 31, 2012.



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Total current assets	$	26,704	$	26,704	$	98,887	$	22,505	$	19,222		$	95,240	$	2,222	$	2,586	$	—		$	—
Total assets	2,200,652		2,065,825		3,236,598		2,939,785		267,407			1,729,776		10,402		8,900		(3,956,783		)	(4,986,010		)
Total current liabilities	16,779		16,289		49,246		20,392		(3,446		)	25,952		1,344		1,290		—			—
Total liabilities	1,797,927		1,663,097		2,982,492		1,650,946		196,430			489,526		2,116		1,685		(3,623,417		)	(2,449,706		)
Total stockholder's equity	402,725		402,728		254,106		1,288,839		70,977			1,240,250		8,286		7,215		(333,366		)	(2,536,304		)

Condensed Consolidating Statement of Cash Flows for the Nine Months Ended December 31, 2011.



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries					Eliminations
	Reported			Revised			Reported			Revised			Reported		Revised			Reported		Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	54,406		$	13,742		$	(4,109	)	$	1,613		$	—	$	31,548		$	169	$	1,090		$	(2,473	)	$	—
Net cash provided by (used in) investing activities	1,060			1,060			(218		)	—			—		(218		)	—		—			—			—
Net cash provided by (used in) financing activities	(64,619		)	(23,955		)	4,327			(1,613		)	—		(31,330		)	120		(801		)	2,473			—

Business and Basis of Presentation (Policies)

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Accounts Receivable

Inventories

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

* Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset.

Goodwill

Intangible Assets

Deferred Financing Costs

Revenue Recognition

Cost of Sales

Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs.

Advertising and Promotion Costs

Stock-based Compensation

Income Taxes

We are subject to taxation in the United States and various state and foreign jurisdictions.

We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.

Earnings Per Share

Recently Issued Accounting Standards

Business and Basis of Presentation (Tables)

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Property and Equipment

Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:



	Years
Machinery	5
Computer equipment	3
Furniture and fixtures	7
Leasehold improvements	*

- Definition

Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

Acquisitions (Tables)

9 Months Ended

Dec. 31, 2012

Business Combinations [Abstract]

Preliminary Purchase Price Allocation

The following table summarizes our allocation of the $663.0 million purchase price to the assets we acquired on the GSK Brands I and GSK Brands II (collectively, the "GSK Brands") acquisition dates:



(In thousands)	GSK Brands I (January 31, 2012)		GSK Brands II (March 30, 2012)		Total
Inventory	$	14,820	$	250	$	15,070
Prepaid expenses	3,575		—		3,575
Trade names	542,892		81,257		624,149
Goodwill	17,401		2,831		20,232
Total purchase price	$	578,688	$	84,338	$	663,026

Unaudited Pro Forma Information



(In thousands, except per share data)	Three Months Ended December 31, 2011		Nine Months Ended December 31, 2011

Revenues	$	157,789	$	461,705
Net income	$	17,204	$	54,724

Earnings per share:
Basic	$	0.34	$	1.09

Diluted	$	0.34	$	1.08

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References+ Details

Divestitures (Tables)

9 Months Ended

Dec. 31, 2012

Discontinued Operations and Disposal Groups [Abstract]

Assets Sold and Associated Assets Held for Sale

The following table presents the assets sold at October 31, 2012 related to the Phazyme brand:



(In thousands)	October 31, 2012
Components of assets sold:
Inventory	$	220
Prepaid expenses	100
Trade names	15,604
Goodwill	6,382

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References+ Details

Accounts Receivable (Tables)

9 Months Ended

Dec. 31, 2012

Receivables [Abstract]

Accounts Receivable

Accounts receivable consist of the following:



(In thousands)	December 31, 2012			March 31, 2012
Components of Accounts Receivable
Trade accounts receivable	$	78,689		$	55,721
Other receivables	1,386			9,368
	80,075			65,089
Less allowances for discounts, returns and uncollectible accounts	(6,323		)	(4,861		)
Accounts receivable, net	$	73,752		$	60,228

Goodwill (Tables)

9 Months Ended

Dec. 31, 2012

Goodwill [Abstract]

Reconciliation of the Activity Affecting Goodwill

A reconciliation of the activity affecting goodwill by operating segment is as follows:



(In thousands)	OTC Healthcare			Household Cleaning			Consolidated

Balance — March 31, 2012
Goodwill	$	296,483		$	72,549		$	369,032
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	166,313			7,389			173,702

Additions	226			—			226
Reductions	(6,382		)	—			(6,382		)

Balance — December 31, 2012
Goodwill	290,327			72,549			362,876
Accumulated impairment losses	(130,170		)	(65,160		)	(195,330		)
	$	160,157		$	7,389		$	167,546

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References+ Details

Intangible Assets (Tables)

9 Months Ended

Dec. 31, 2012

Intangible Assets [Abstract]

Reconciliation of the Activity Affecting Intangible Assets

A reconciliation of the activity affecting intangible assets is as follows:



(In thousands)	Indefinite Lived Trademarks		Finite Lived Trademarks			Non Compete Agreement		Totals
Gross Carrying Amounts
Balance — March 31, 2012	$	1,245,414	$	217,512		$	158	$	1,463,084
Reductions	—		(16,142		)	—		(16,142		)
Balance — December 31, 2012	$	1,245,414	$	201,370		$	158	$	1,446,942

Accumulated Amortization
Balance — March 31, 2012	$	—	$	62,404		$	158	$	62,562
Additions	—		8,980			—		8,980
Reductions	—		(538		)	—		(538		)
Balance — December 31, 2012	$	—	$	70,846		$	158	$	71,004

Intangible assets, net - December 31, 2012	$	1,245,414	$	130,524		$	—	$	1,375,938

Schedule of Expected Amortization Expense

At December 31, 2012, finite-lived intangible assets are being amortized over a period of 3 to 30 years, and the associated amortization expense is expected to be as follows:



(In thousands)
Year Ending March 31,	Amount
2013 (Remaining three months ending March 31, 2013)	$	2,745
2014	10,175
2015	8,840
2016	8,840
2017	8,840
Thereafter	91,084
	$	130,524

Long-Term Debt (Tables)

9 Months Ended

Dec. 31, 2012

Debt Disclosure [Abstract]

Schedule of Long-term Debt

Long-term debt consists of the following, as of the dates indicated:



(In thousands, except percentages)	December 31, 2012			March 31, 2012
2012 Senior Notes bearing interest at 8.125%, with interest only payable on February 1 and August 1 of each year. The 2012 Senior Notes mature on February 1, 2020.	$	250,000		$	250,000
2012 Term Loan bearing interest at the Company's option at either a base rate plus applicable margin with a floor of 2.25% or LIBOR with a floor of 1.25%, due on January 31, 2019.	467,500			635,000
2012 ABL Revolver bearing interest at the Company's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 31, 2017.	40,000			—
2010 Senior Notes bearing interest at 8.25%, with interest only payable on April 1 and October 1 of each year. The 2010 Senior Notes mature on April 1, 2018.	250,000			250,000
	1,007,500			1,135,000
Current portion of long-term debt	—			—
	1,007,500			1,135,000
Less: unamortized discount	(7,200		)	(11,092		)
Long-term debt, net of unamortized discount	$	1,000,300		$	1,123,908

Aggregate Future Principal Payments

Aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, the 2012 ABL Revolver and the indentures governing the 2010 Senior Notes and the 2012 Senior Notes are as follows:



(In thousands)
Year Ending March 31,	Amount
2013 (remaining three months ending March 31, 2013)	$	—
2014	—
2015	—
2016	—
2017	40,000
Thereafter	967,500
	$	1,007,500

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Dec. 31, 2012

Accumulated Other Comprehensive Income [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

AOCI consisted of the following at December 31, 2012 and March 31, 2012:



	December 31,		March 31,
(In thousands)	2012		2012
Components of Accumulated Other Comprehensive Income (Loss)
Cumulative translation adjustment	$	10	$	(13	)
Total accumulated other comprehensive loss	$	10	$	(13	)

Earnings Per Share (Tables)

9 Months Ended

Dec. 31, 2012

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended December 31,				Nine Months Ended December 31,
(In thousands, except per share data)	2012		2011		2012		2011
Numerator
Net income	$	12,257	$	9,510	$	46,156	$	37,227

Denominator
Denominator for basic earnings per share — weighted average shares outstanding	50,686		50,307		50,465		50,256
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors	837		377		820		411
Denominator for diluted earnings per share	51,523		50,684		51,285		50,667

Earnings per Common Share:
Basic net earnings per share	$	0.24	$	0.19	$	0.91	$	0.74

Diluted net earnings per share	$	0.24	$	0.19	$	0.90	$	0.73

Share-Based Compensation (Tables)

9 Months Ended

Dec. 31, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Restricted Shares

A summary of the Company's restricted shares granted under the Plan is presented below:



Restricted Shares	Shares (in thousands)		Weighted- Average Grant-Date Fair Value
Nine months ended December 31, 2011:
Outstanding at March 31, 2011	275.4		$	8.46
Granted	122.5		11.35
Vested and issued	(103.4	)	9.93
Forfeited	(15.2	)	10.72
Outstanding at December 31, 2011	279.3		9.06
Vested at December 31, 2011	54.0		7.40

Nine months ended December 31, 2012:
Outstanding at March 31, 2012	363.4		$	9.92
Granted	128.9		13.59
Vested and issued	(27.0	)	7.16
Forfeited	(12.3	)	10.69
Outstanding at December 31, 2012	453.0		11.11
Vested at December 31, 2012	70.4		8.52

Stock Options, Valuation Assumptions



	Nine Months Ended December 31,
	2012			2011
Expected volatility	44.0		%	53.0		%
Expected dividends	$	—		$	—
Expected term in years	6.5			6.5
Risk-free rate	1.2		%	2.4		%

Stock Option Activity

A summary of option activity under the Plan is as follows:



Options	Shares (in thousands)		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)
Nine months ended December 31, 2011:
Outstanding at March 31, 2011	1,621.5		$	8.19
Granted	308.1		11.27
Exercised	(54.2	)	10.54
Forfeited or expired	(78.9	)	11.93
Outstanding at December 31, 2011	1,796.5		8.48		7.9	$	5,125
Exercisable at December 31, 2011	678.0		8.43		7.4	2,035

Nine months ended December 31, 2012:
Outstanding at March 31, 2012	1,745.4		$	8.44
Granted	444.9		13.36
Exercised	(708.5	)	7.71
Forfeited or expired	(17.4	)	11.21
Outstanding at December 31, 2012	1,464.4		10.26		7.7	$	11,330
Exercisable at December 31, 2012	332.4		9.99		6.8	2,248

Commitments and Contingencies (Tables)

9 Months Ended

Dec. 31, 2012

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

The following summarizes future minimum lease payments for our operating leases as of December 31, 2012:



(In thousands)
Year Ending March 31,	Facilities		Equipment		Total
2013 (Remaining three months ending March 31, 2013)	$	275	$	36	$	311
2014	1,764		141		1,905
2015	1,049		136		1,185
2016	994		135		1,129
2017	1,023		68		1,091
Thereafter	1,044		—		1,044
	$	6,149	$	516	$	6,665

Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]

e entered into a 10 year supply agreement for the exclusive manufacture of a portion of one of our Household Cleaning products. Although we are committed under the supply agreement to pay the minimum amounts set forth in the table below, the total commitment is less than ten percent of the estimated purchases that we expect to make during the course of the agreement. Additionally, we entered into a short-term supply arrangement with one of our Canadian suppliers to provide a certain amount of product through January 2013. As such, we have included $3.2 million of purchase commitments in the remaining three months ended March 31, 2013.



(In thousands)
Year Ending March 31,	Amount
2013 (Remaining three months ending March 31, 2013)	$	3,460
2014	1,136
2015	1,105
2016	1,074
2017	1,044
Thereafter	2,555
	$	10,374

- Definition

Tabular disclosure of unconditional purchase obligations that are not recognized as a liability on the balance sheet, including the nature and significant terms of an unconditional purchase obligation; the amount of the fixed and determinable portion of the obligation as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each of the five succeeding fiscal years; the nature of any variable components of the obligation; the amount purchased under the obligation (for example, the take-or-pay or throughput contract) for the reporting period; and may include the amount of imputed interest necessary to reduce the obligation to present value.

+ References+ Details

Business Segments (Tables)

9 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Information about our Operating and Reportable Segments

The tables below summarize information about our operating and reportable segments.



	Three Months Ended December 31, 2012						Nine Months Ended December 31, 2012
(In thousands)	OTC Healthcare		Household Cleaning		Consolidated		OTC Healthcare		Household Cleaning		Consolidated
Net sales	$	138,858	$	20,634	$	159,492	$	402,633	$	64,102	$	466,735
Other revenues	175		565		740		520		1,829		2,349
Total revenues	139,033		21,199		160,232		403,153		65,931		469,084
Cost of sales	59,381		15,854		75,235		160,249		49,689		209,938
Gross profit	79,652		5,345		84,997		242,904		16,242		259,146
Advertising and promotion	22,410		1,128		23,538		62,309		5,062		67,371
Contribution margin	$	57,242	$	4,217	61,459		$	180,595	$	11,180	191,775
Other operating expenses					14,737						50,064
Operating income					46,722						141,711
Other expense					26,661						66,169
Income before income taxes					20,061						75,542
Provision for income taxes					7,804						29,386
Net income					$	12,257					$	46,156



	Three Months Ended December 31, 2011						Nine Months Ended December 31, 2011
(In thousands)	OTC Healthcare		Household Cleaning		Consolidated		OTC Healthcare		Household Cleaning		Consolidated
Net sales	$	84,711	$	21,088	$	105,799	$	234,712	$	69,966	$	304,678
Other revenues	195		256		451		552		1,859		2,411
Total revenues	84,906		21,344		106,250		235,264		71,825		307,089
Cost of sales	35,329		15,799		51,128		97,198		50,995		148,193
Gross profit	49,577		5,545		55,122		138,066		20,830		158,896
Advertising and promotion	14,170		1,104		15,274		34,746		3,834		38,580
Contribution margin	$	35,407	$	4,441	39,848		$	103,320	$	16,996	120,316
Other operating expenses					16,218						40,049
Operating income					23,630						80,267
Other expense					8,116						19,910
Income before income taxes					15,514						60,357
Provision for income taxes					6,004						23,130
Net income					$	9,510					$	37,227

Information about our Revenues from Similar Product Groups



	Three Months Ended December 31,		Nine Months Ended December 31,
(In thousands)	2012	2011	2012	2011
Analgesics	27,946	597	81,727	1,955
Cough & Cold	37,424	40,621	94,197	89,858
Gastrointestinal	24,977	3,480	74,510	13,924
Eye & Ear Care	19,702	17,091	63,109	53,940
Dermatologicals	11,496	10,580	41,578	39,060
Oral Care	12,953	11,501	36,032	33,712
Other OTC	4,535	1,036	12,000	2,815
Total OTC Healthcare Segment	139,033	84,906	403,153	235,264
Household Cleaning Segment	21,199	21,344	65,931	71,825
Consolidated Total Revenues	160,232	106,250	469,084	307,089

Allocation of Long-Term Assets to Segments

At December 31, 2012, substantially all of our long-term assets were located in the United States and have been allocated to the operating segments as follows:



(In thousands)	OTC Healthcare		Household Cleaning		Consolidated
Goodwill	$	160,157	$	7,389	$	167,546

Intangible assets
Indefinite-lived	1,125,594		119,820		1,245,414
Finite-lived	102,177		28,347		130,524
	1,227,771		148,167		1,375,938

	$	1,387,928	$	155,556	$	1,543,484

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Condensed Consolidating Financial Statements (Tables)

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Statements of Income and Comprehensive Income

Three Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	25,345		$	132,881		$	1,266		$	—		$	159,492
Other revenues	—			79			724			276			(339		)	740
Total revenues	—			25,424			133,605			1,542			(339		)	160,232

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			9,877			65,172			525			(339		)	75,235
Gross profit	—			15,547			68,433			1,017			—			84,997

Operating Expenses
Advertising and promotion	—			3,032			19,997			509			—			23,538
General and administrative	952			1,585			8,734			107			—			11,378
Depreciation and amortization	549			140			2,658			12			—			3,359
Total operating expenses	1,501			4,757			31,389			628			—			38,275
Operating income (loss)	(1,501		)	10,790			37,044			389			—			46,722

Other (income) expense
Interest income	33			(41,552		)	162			(62		)	41,415			(4		)
Interest expense	8,735			35,394			23,951			—			(41,415		)	26,665
Equity in income of subsidiaries	(18,531		)	(8,407		)	(393		)	—			27,331			—
Total other (income) expense	(9,763		)	(14,565		)	23,720			(62		)	27,331			26,661
Income before income taxes	8,262			25,355			13,324			451			(27,331		)	20,061
Provision (benefit) for income taxes	(3,995		)	6,593			5,030			176			—			7,804
Net income (loss)	$	12,257		$	18,762		$	8,294		$	275		$	(27,331	)	$	12,257

Comprehensive income, net of tax:
Currency translation adjustments	(1		)	—			—			1			(1		)	(1		)
Total other comprehensive income (loss)	(1		)	—			—			1			(1		)	(1		)
Comprehensive income (loss)	$	12,256		$	18,762		$	8,294		$	276		$	(27,332	)	$	12,256

Condensed Consolidating Statements of Income and Comprehensive Income

Nine Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	75,294		$	387,815		$	3,626		$	—		$	466,735
Other revenues	—			220			2,310			1,270			(1,451		)	2,349
Total revenues	—			75,514			390,125			4,896			(1,451		)	469,084

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			28,493			181,382			1,514			(1,451		)	209,938
Gross profit	—			47,021			208,743			3,382			—			259,146

Operating Expenses
Advertising and promotion	—			8,917			57,326			1,128			—			67,371
General and administrative	3,676			5,020			30,802			616			—			40,114
Depreciation and amortization	818			420			8,667			45			—			9,950
Total operating expenses	4,494			14,357			96,795			1,789			—			117,435
Operating income (loss)	(4,494		)	32,664			111,948			1,593			—			141,711

Other (income) expense
Interest income	(24,337		)	(63,573		)	162			(163		)	87,902			(9		)
Interest expense	26,147			92,320			35,613			—			(87,902		)	66,178
Equity in income of subsidiaries	(50,008		)	(49,280		)	(1,306		)	—			100,594			—
Total other (income) expense	(48,198		)	(20,533		)	34,469			(163		)	100,594			66,169
Income before income taxes	43,704			53,197			77,479			1,756			(100,594		)	75,542
Provision (benefit) for income taxes	(2,452		)	1,524			29,631			683			—			29,386
Net income (loss)	$	46,156		$	51,673		$	47,848		$	1,073		$	(100,594	)	$	46,156

Comprehensive income, net of tax:
Currency translation adjustments	23			—			—			(23		)	23			23
Total other comprehensive income (loss)	23			—			—			(23		)	23			23
Comprehensive income (loss)	$	46,179		$	51,673		$	47,848		$	1,050		$	(100,571	)	$	46,179

Condensed Consolidating Statements of Income and Comprehensive Income

Three Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	27,352		$	77,308	$	1,139		$	—		$	105,799
Other revenues	—			57			451		227			(284		)	451
Total revenues	—			27,409			77,759		1,366			(284		)	106,250

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			9,784			41,154		474			(284		)	51,128
Gross profit	—			17,625			36,605		892			—			55,122

Operating Expenses
Advertising and promotion	3			3,431			11,216		624			—			15,274
General and administrative	5,318			2,322			5,684		331			—			13,655
Depreciation and amortization	135			143			2,267		18			—			2,563
Total operating expenses	5,456			5,896			19,167		973			—			31,492
Operating income (loss)	(5,456		)	11,729			17,438		(81		)	—			23,630

Other (income) expense
Interest income	(12,302		)	(11,118		)	—		(60		)	23,479			(1		)
Interest expense	8,791			16,907			5,898		—			(23,479		)	8,117
Equity in income of subsidiaries	(10,727		)	(7,936		)	39		—			18,624			—
Total other (income) expense	(14,238		)	(2,147		)	5,937		(60		)	18,624			8,116
Income (loss) before income taxes	8,782			13,876			11,501		(21		)	(18,624		)	15,514
Provision (benefit) for income taxes	(728		)	2,285			4,454		(7		)	—			6,004
Net income (loss)	9,510			11,591			7,047		(14		)	(18,624		)	9,510

Comprehensive income, net of tax:
Currency translation adjustments	(18		)	—			—		(18		)	18			(18		)
Total other comprehensive income (loss)	(18		)	—			—		(18		)	18			(18		)
Comprehensive income (loss)	$	9,492		$	11,591		$	7,047	$	(32	)	$	(18,606	)	$	9,492

Condensed Consolidating Statements of Income and Comprehensive Income

Nine Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Revenues
Net sales	$	—		$	74,767		$	226,859		$	3,052		$	—		$	304,678
Other revenues	—			178			2,386			1,131			(1,284		)	2,411
Total revenues	—			74,945			229,245			4,183			(1,284		)	307,089

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	—			27,191			121,032			1,254			(1,284		)	148,193
Gross profit	—			47,754			108,213			2,929			—			158,896

Operating Expenses
Advertising and promotion	3			9,341			28,133			1,103			—			38,580
General and administrative	5,514			7,502			18,538			812			—			32,366
Depreciation and amortization	412			428			6,789			54			—			7,683
Total operating expenses	5,929			17,271			53,460			1,969			—			78,629
Operating income (loss)	(5,929		)	30,483			54,753			960			—			80,267

Other (income) expense
Interest income	(38,196		)	(33,291		)	—			(173		)	71,656			(4		)
Interest expense	26,323			51,299			19,011			—			(71,656		)	24,977
Gain on settlement	(5,063		)	—			—			—			—			(5,063		)
Equity in income of subsidiaries	(30,438		)	(23,768		)	(745		)	—			54,951			—
Total other (income) expense	(47,374		)	(5,760		)	18,266			(173		)	54,951			19,910
Income (loss) before income taxes	41,445			36,243			36,487			1,133			(54,951		)	60,357
Provision (benefit) for income taxes	4,218			4,781			13,697			434			—			23,130
Net income (loss)	37,227			31,462			22,790			699			(54,951		)	37,227

Comprehensive income, net of tax:
Currency translation adjustments	(70		)	—			—			(70		)	70			(70		)
Total other comprehensive income (loss)	(70		)	—			—			(70		)	70			(70		)
Comprehensive income (loss)	$	37,157		$	31,462		$	22,790		$	629		$	(54,881	)	$	37,157

Condensed Consolidating Balance Sheet

December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries		Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	8,878		$	—		$	—	$	1,553	$	—		$	10,431
Accounts receivable, net	140			13,217			59,428		967		—			73,752
Inventories	—			9,340			44,218		692		—			54,250
Deferred income tax assets	213			730			5,651		—		—			6,594
Prepaid expenses and other current assets	1,656			425			4,101		13		—			6,195
Total current assets	10,887			23,712			113,398		3,225		—			151,222

Property and equipment, net	8,987			25			178		—		—			9,190
Goodwill	—			66,007			101,539		—		—			167,546
Intangible assets, net	—			193,530			1,182,074		334		—			1,375,938
Other long-term assets	—			27,493			—		—		—			27,493
Intercompany receivable	1,284,415			1,933,896			420,375		7,537		(3,646,223		)	—
Investment in subsidiary	808,377			622,107			6,890		—		(1,437,374		)	—
Total Assets	$	2,112,666		$	2,866,770		$	1,824,454	$	11,096	$	(5,083,597	)	$	1,731,389

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	2,275		$	7,304		$	30,012	$	1,267	$	—		$	40,858
Accrued interest payable	—			13,620			—		—		—			13,620
Other accrued liabilities	10,571			2,485			19,958		1,258		—			34,272
Total current liabilities	12,846			23,409			49,970		2,525		—			88,750

Long-term debt
Principal amount	—			1,007,500			—		—		—			1,007,500
Less unamortized discount	—			(7,200		)	—		—		—			(7,200		)
Long-term debt, net of unamortized discount	—			1,000,300			—		—		—			1,000,300

Deferred income tax liabilities	—			50,869			134,059		79		—			185,007
Intercompany payable	1,642,488			451,454			1,552,100		181		(3,646,223		)	—
Total Liabilities	1,655,334			1,526,032			1,736,129		2,785		(3,646,223		)	1,274,057

Stockholders' Equity
Preferred share rights	283			—			—		—		—			283
Common stock	512			—			—		—		—			512
Additional paid-in capital	400,316			1,280,945			39,724		1,111		(1,321,780		)	400,316
Treasury stock, at cost - 181 shares	(687		)	—			—		—		—			(687		)
Accumulated other comprehensive income, net of tax	10			—			—		10		(10		)	10
Retained earnings (accumulated deficit)	56,898			59,793			48,601		7,190		(115,584		)	56,898
Total Stockholders' Equity	457,332			1,340,738			88,325		8,311		(1,437,374		)	457,332
Total Liabilities and Stockholders' Equity	$	2,112,666		$	2,866,770		$	1,824,454	$	11,096	$	(5,083,597	)	$	1,731,389

Condensed Consolidating Balance Sheet

March 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors		Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	18,221		$	—		$	—	$	794		$	—		$	19,015
Accounts receivable, net	25			13,502			45,954		747			—			60,228
Inventories	—			8,098			42,334		681			—			51,113
Deferred income tax assets	356			849			4,078		—			—			5,283
Prepaid expenses and other current assets	8,102			56			2,874		364			—			11,396
Total current assets	26,704			22,505			95,240		2,586			—			147,035

Property and equipment, net	934			22			346		2			—			1,304
Goodwill	—			66,007			107,695		—			—			173,702
Intangible assets, net	—			193,932			1,206,213		377			—			1,400,522
Other long-term assets	—			35,713			—		—			—			35,713
Intercompany receivable	680,067			1,449,005			314,699		5,935			(2,449,706		)	—
Investment in subsidiary	1,358,120			1,172,601			5,583		—			(2,536,304		)	—
Total Assets	$	2,065,825		$	2,939,785		$	1,729,776	$	8,900		$	(4,986,010	)	$	1,758,276

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	4,531		$	4,816		$	17,008	$	371		$	—		$	26,726
Accrued interest payable	—			13,889			—		—			—			13,889
Other accrued liabilities	11,758			1,687			8,944		919			—			23,308
Total current liabilities	16,289			20,392			25,952		1,290			—			63,923

Long-term debt
Principal amount	—			1,135,000			—		—			—			1,135,000
Less unamortized discount	—			(11,092		)	—		—			—			(11,092		)
Long-term debt, net of unamortized discount	—			1,123,908			—		—			—			1,123,908

Deferred income tax liabilities	—			50,944			116,690		83			—			167,717
Intercompany payable	1,646,808			455,702			346,884		312			(2,449,706		)	—
Total Liabilities	1,663,097			1,650,946			489,526		1,685			(2,449,706		)	1,355,548

Stockholders' Equity
Preferred share rights	283			—			—		—			—			283
Common stock	505			—			—		—			—			505
Additional paid-in capital	391,898			1,280,719			1,239,497		1,111			(2,521,327		)	391,898
Treasury stock, at cost - 181 shares	(687		)	—			—		—			—			(687		)
Accumulated other comprehensive loss, net of tax	(13		)	—			—		(13		)	13			(13		)
Retained earnings (accumulated deficit)	10,742			8,120			753		6,117			(14,990		)	10,742
Total Stockholders' Equity	402,728			1,288,839			1,240,250		7,215			(2,536,304		)	402,728
Total Liabilities and Stockholders' Equity	$	2,065,825		$	2,939,785		$	1,729,776	$	8,900		$	(4,986,010	)	$	1,758,276

Condensed Consolidating Statement of Cash Flows

Nine Months Ended December 31, 2012



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non- Guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	46,156		$	51,673		$	47,848		$	1,073		$	(100,594	)	$	46,156
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	818			420			8,667			45			—			9,950
Deferred income taxes	143			44			15,796			(4		)	—			15,979
Amortization of deferred financing costs	—			8,220			—			—			—			8,220
Stock-based compensation costs	2,965			—			—			—			—			2,965
Amortization of debt discount	—			3,892			—			—			—			3,892
Lease termination costs	975			—			—			—			—			975
Loss on disposal of equipment	30			—			21			—			—			51
Equity in income of subsidiaries	(50,008		)	(49,280		)	(1,306		)	—			100,594			—
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(115		)	285			(13,474		)	(214		)	—			(13,518		)
Inventories	—			(1,242		)	(2,104		)	(5		)	—			(3,351		)
Prepaid expenses and other current assets	6,446			(369		)	(627		)	351			—			5,801
Accounts payable	(3,347		)	2,488			14,095			889			—			14,125
Accrued liabilities	(1,071		)	529			9,830			343			—			9,631
Net cash provided by operating activities	2,992			16,660			78,746			2,478			—			100,876

Investing Activities
Purchases of property and equipment	(8,922		)	—			—			—			—			(8,922		)
Proceeds from the sale of property and equipment	—			—			15			—			—			15
Proceeds from the sale of the Phazyme brand	—			—			21,700			—			—			21,700
Acquisition of brands from GSK purchase price adjustments	—			—			(226		)	—			—			(226		)
Intercompany activity, net	(226		)	—			226			—			—			—
Net cash provided by (used in) investing activities	(9,148		)	—			21,715			—			—			12,567

Financing Activities
Repayments of long-term debt	—			(167,500		)	—			—			—			(167,500		)
Repayments under revolving credit agreement	—			(8,000		)	—			—			—			(8,000		)
Borrowings under revolving credit agreement	—			48,000			—			—			—			48,000
Proceeds from exercise of stock options	5,460			—			—			—			—			5,460
Intercompany activity, net	(8,647		)	110,840			(100,461		)	(1,732		)	—			—
Net cash used in financing activities	(3,187		)	(16,660		)	(100,461		)	(1,732		)	—			(122,040		)

Effect of exchange rate changes on cash and cash equivalents	—			—			—			13			—			13
(Decrease) increase in cash and cash equivalents	(9,343		)	—			—			759			—			(8,584		)
Cash - beginning of period	18,221			—			—			794			—			19,015
Cash - end of period	$	8,878		$	—		$	—		$	1,553		$	—		$	10,431

Condensed Consolidating Statement of Cash Flows

Nine Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.			Prestige Brands, Inc., the issuer			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Operating Activities
Net income (loss)	$	37,227		$	31,462		$	22,790		$	699		$	(54,951	)	$	37,227
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	412			428			6,789			54			—			7,683
Deferred income taxes	427			1,612			5,293			(11		)	—			7,321
Amortization of deferred financing costs	—			847			—			—			—			847
Stock-based compensation costs	2,360			—			—			—			—			2,360
Amortization of debt discount	—			687			—			—			—			687
Equity in income of subsidiaries	(30,438		)	(23,768		)	(745		)	—			54,951			—
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(23		)	(2,930		)	(2,671		)	(192		)	—			(5,816		)
Inventories	—			(1,053		)	(2,822		)	25			—			(3,850		)
Prepaid expenses and other current assets	3,219			(138		)	(418		)	(13		)	—			2,650
Accounts payable	(31		)	(502		)	2,571			354			—			2,392
Accrued liabilities	589			(5,032		)	761			174			—			(3,508		)
Net cash provided by operating activities	13,742			1,613			31,548			1,090			—			47,993

Investing Activities
Purchases of property and equipment	(140		)	—			(218		)	—			—			(358		)
Proceeds from escrow of Blacksmith acquisition	—			—			1,200			—			—			1,200
Intercompany activity, net	1,200			—			(1,200		)	—			—			—
Net cash provided by (used in) investing activities	1,060			—			(218		)	—			—			842

Financing Activities
Repayment of long-term debt	—			(58,000		)	—			—			—			(58,000		)
Proceeds from exercise of stock options	572			—			—			—			—			572
Shares surrendered as payment of tax withholding	(271		)	—			—			—			—			(271		)
Intercompany activity, net	(24,256		)	56,387			(31,330		)	(801		)	—			—
Net cash used in financing activities	(23,955		)	(1,613		)	(31,330		)	(801		)	—			(57,699		)

Effect of exchange rate changes on cash and cash equivalents	—			—			—			(31		)	—			(31		)
Increase in cash and cash equivalents	(9,153		)	—			—			258			—			(8,895		)
Cash - beginning of period	12,698			—			—			636			—			13,334
Cash - end of period	$	3,545		$	—		$	—		$	894		$	—		$	4,439

Schedule of Quantifying Prior Year Misstatements Corrected in Current Year Financial Statements

The Company will disclose the impact of the revisions on previously reported amounts and accordingly revise the Condensed Consolidated Financial Statements for comparative periods in its future filings. The impact of these revisions as of March 31, 2012 and for each of the three and nine month periods ended December 31, 2011 are shown in the following tables:

Condensed Consolidating Statement of Income and Comprehensive Income for the Three Months Ended December 31, 2011



(In thousands)	Prestige Brands Holdings, Inc.					Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries						Eliminations
	Reported		Revised			Reported		Revised		Reported			Revised		Reported			Revised			Reported			Revised
Revenue	$	—	$	—		$	83,768	$	27,409	$	21,343		$	77,759	$	1,423		$	1,366		$	(284	)	$	(284	)
Income before income taxes	13,575		8,782			6,402		13,876		(1,316		)	11,501		(22		)	(21		)	(3,125		)	(18,624		)
Provision (benefit) for income taxes	4,065		(728		)	2,430		2,285		(509		)	4,454		18			(7		)	—			—
Net income	9,510		9,510			3,972		11,591		(807		)	7,047		(40		)	(14		)	(3,125		)	(18,624		)

Condensed Consolidating Statement of Income and Comprehensive Income for the Nine Months Ended December 31, 2011.



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Revenue	$	—	$	—	$	232,214	$	74,945	$	71,823		$	229,245	$	4,336	$	4,183	$	(1,284	)	$	(1,284	)
Income before income taxes	52,806		41,445		20,701		36,243		(2,163		)	36,487		1,132		1,133		(12,119		)	(54,951		)
Provision (benefit) for income taxes	15,579		4,218		8,000		4,781		(837		)	13,697		388		434		—			—
Net income	37,227		37,227		12,701		31,462		(1,326		)	22,790		744		699		(12,119		)	(54,951		)

Condensed Consolidating Balance sheet as of March 31, 2012.



(In thousands)	Prestige Brands Holdings, Inc.				Prestige Brands, Inc., the issuer				Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries				Eliminations
	Reported		Revised		Reported		Revised		Reported			Revised		Reported		Revised		Reported			Revised
Total current assets	$	26,704	$	26,704	$	98,887	$	22,505	$	19,222		$	95,240	$	2,222	$	2,586	$	—		$	—
Total assets	2,200,652		2,065,825		3,236,598		2,939,785		267,407			1,729,776		10,402		8,900		(3,956,783		)	(4,986,010		)
Total current liabilities	16,779		16,289		49,246		20,392		(3,446		)	25,952		1,344		1,290		—			—
Total liabilities	1,797,927		1,663,097		2,982,492		1,650,946		196,430			489,526		2,116		1,685		(3,623,417		)	(2,449,706		)
Total stockholder's equity	402,725		402,728		254,106		1,288,839		70,977			1,240,250		8,286		7,215		(333,366		)	(2,536,304		)

Condensed Consolidating Statement of Cash Flows for the Nine Months Ended December 31, 2011.



(In thousands)	Prestige Brands Holdings, Inc.						Prestige Brands, Inc., the issuer						Combined Subsidiary Guarantors					Combined Non-Guarantor Subsidiaries					Eliminations
	Reported			Revised			Reported			Revised			Reported		Revised			Reported		Revised			Reported			Revised
Net cash provided by (used in) operating activities	$	54,406		$	13,742		$	(4,109	)	$	1,613		$	—	$	31,548		$	169	$	1,090		$	(2,473	)	$	—
Net cash provided by (used in) investing activities	1,060			1,060			(218		)	—			—		(218		)	—		—			—			—
Net cash provided by (used in) financing activities	(64,619		)	(23,955		)	4,327			(1,613		)	—		(31,330		)	120		(801		)	2,473			—

Business and Basis of Presentation (Property and Equipment) (Details)

9 Months Ended

Dec. 31, 2012

Machinery

Property, Plant and Equipment [Line Items]

Property and equipment, useful lives

5 years

Computer Equipment

Property, Plant and Equipment [Line Items]

Property and equipment, useful lives

3 years

Furniture and Fixtures

Property, Plant and Equipment [Line Items]

Property and equipment, useful lives

7 years

Leasehold Improvements

Property, Plant and Equipment [Line Items]

Property and equipment, useful lives

^[1]

[1]	Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset.

Business and Basis of Presentation (Other Balance Sheet and Income Statement Items) (Details) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012
Other Balance Sheet and Income Statement Items [Line Items]
Term of original maturities, cash equivalents, up to and including			3 months
Shipping, warehousing and handling costs	$ 7,600,000	$ 6,900,000	$ 23,100,000	$ 20,100,000
Accounts receivable, net	73,752,000		73,752,000		60,228,000
GSK Brands
Other Balance Sheet and Income Statement Items [Line Items]
Accounts receivable, net	$ 0		$ 0		$ 8,400,000

- Definition

Cost incurred during the reporting period in transporting goods and services to customers. Includes freight-out costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6408196&loc=d3e61069-111654

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Handling Costs

-URI http://asc.fasb.org/extlink&oid=6514758

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=21915142&loc=d3e60635-111653

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6408413&loc=d3e221937-122793

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Shipping Costs

-URI http://asc.fasb.org/extlink&oid=6525344

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 00-10

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Acquisitions (Narrative) (Details) (USD $)	9 Months Ended		2 Months Ended	3 Months Ended	9 Months Ended				1 Months Ended		1 Months Ended			0 Months Ended	3 Months Ended	9 Months Ended
Acquisitions (Narrative) (Details) (USD $)	Dec. 31, 2012	Dec. 31, 2011	May 31, 2012 GSK Brands	Dec. 31, 2012 GSK Brands	Dec. 31, 2012 GSK Brands	Mar. 31, 2012 GSK Brands	Jan. 31, 2012 GSK Brands brand	Dec. 20, 2011 GSK Brands agreement	Apr. 30, 2012 GSK Brands I	Jan. 31, 2012 GSK Brands I brand	May 31, 2012 GSK Brands II	Mar. 31, 2012 GSK Brands II	Mar. 30, 2012 GSK Brands II	Mar. 30, 2012 GSK	Dec. 31, 2012 GSK	Dec. 31, 2012 GSK
Business Acquisition [Line Items]
Number of purchase agreements								2
Number of brands acquired							17			15
Cash paid for acquisition						$ 660,000,000				$ 615,000,000		$ 45,000,000
Post-closing adjustments added to purchase price	226,000	0	3,000,000						2,800,000		200,000
Transitional services agreement, estimated monthly costs to be incurred														2,500,000
Transitional services agreement, actual costs incurred															0	6,900,000
Purchase price						663,026,000				578,688,000			84,338,000
Goodwill, expected tax deductible amount						20,200,000
Non-amortizable intangible assets						556,900,000
Amortizable intangible assets						67,200,000
Purchased amortizable intangible assets, weighted average useful life					19 years 3 months 18 days
Amortizable intangible assets, weighted average remaining life	13 years				18 years 2 months 0 days
Revenue of acquiree since acquisition date, actual				56,900,000	159,900,000
Net income of acquiree since acquisition date, actual				$ 8,700,000	$ 18,400,000

Acquisitions (Purchase Price Allocation) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012 GSK Brands	Jan. 31, 2012 GSK Brands I	Mar. 30, 2012 GSK Brands II
Business Acquisition [Line Items]
Inventory	$ 15,070	$ 14,820	$ 250
Prepaid expenses	3,575	3,575	0
Trade names	624,149	542,892	81,257
Goodwill	20,232	17,401	2,831
Total purchase price	$ 663,026	$ 578,688	$ 84,338

Acquisitions (Pro Forma Information) (Details) (GSK Brands, USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended	9 Months Ended
	Dec. 31, 2011	Dec. 31, 2011
GSK Brands
Business Acquisition [Line Items]
Revenues	$ 157,789	$ 461,705
Net income	$ 17,204	$ 54,724
Earnings per share:
Basic (in USD per share)	$ 0.34	$ 1.09
Diluted (in USD per share)	$ 0.34	$ 1.08

- Definition

The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

- Definition

The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

Divestitures (Details) (Sale of Phazyme Brand, USD $) In Thousands, unless otherwise specified	Oct. 31, 2012
Sale of Phazyme Brand
Assets sold
Inventory	$ 220
Prepaid expenses	100
Trade names	15,604
Goodwill	$ 6,382

Divestitures (Narrative) (Details) (USD $)	9 Months Ended		0 Months Ended	3 Months Ended	0 Months Ended
Divestitures (Narrative) (Details) (USD $)	Dec. 31, 2012	Dec. 31, 2011	Oct. 31, 2012 Sale of Phazyme Brand	Dec. 31, 2012 Sale of Phazyme Brand	Jan. 04, 2013 Subsequent Event Sale of Phazyme Brand
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from the sale of the Phazyme brand	$ 21,700,000	$ 0	$ 21,700,000		$ 600,000
Fees earned from Transitional Services Agreement				$ 100,000

Accounts Receivable (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 80,075,000	$ 65,089,000
Less allowances for discounts, returns and uncollectible accounts	(6,323,000)	(4,861,000)
Accounts receivable, net	73,752,000	60,228,000
Trade Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	78,689,000	55,721,000
Other Receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 1,386,000	$ 9,368,000

Inventories (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Inventory Disclosure [Abstract]
Packaging and raw materials	$ 2,375,000	$ 1,189,000
Finished goods	51,875,000	49,924,000
Inventories	54,250,000	51,113,000
Inventory valuation reserves related to obsolete and slow-moving inventory	$ 1,800,000	$ 1,600,000

- Definition

The amount of the valuation account as of the balance sheet date which reduces the carrying amount of inventory to net realizable value; takes into consideration such factors as market value, excessive quantities based on expected sales, technological obsolescence, and shrinkage. May also provide for estimated product returns or price concessions pertaining to product cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 9

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=6386940&loc=d3e100047-122729

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SX 210.12-09)

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e24092-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Paragraph 14

-Chapter 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Paragraph 8, 9, 14

-Chapter 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Property and Equipment (Details) (USD $)	3 Months Ended		9 Months Ended
Property and Equipment (Details) (USD $)	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012
Components of Property and Equipment
Property and equipment, gross	$ 13,076,000		$ 13,076,000		$ 4,824,000
Accumulated depreciation	(3,886,000)		(3,886,000)		(3,520,000)
Property and equipment, net	9,190,000		9,190,000		1,304,000
Depreciation	400,000	200,000	1,000,000	600,000
Machinery
Components of Property and Equipment
Property and equipment, gross	1,443,000		1,443,000		1,454,000
Computer Equipment
Components of Property and Equipment
Property and equipment, gross	5,398,000		5,398,000		2,693,000
Furniture and Fixtures
Components of Property and Equipment
Property and equipment, gross	1,523,000		1,523,000		241,000
Leasehold Improvements
Components of Property and Equipment
Property and equipment, gross	4,712,000		4,712,000		436,000
Impairment of assets	$ 100,000

- Definition

The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.

+ References+ Details

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References+ Details

- Definition

The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 26

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 958

-SubTopic 225

-Section 45

-Paragraph 11

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6743430&loc=d3e92212-112881

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Impairment

-URI http://asc.fasb.org/extlink&oid=6515133

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 7, 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References+ Details

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References+ Details

Goodwill (Details) (USD $)	9 Months Ended			3 Months Ended
Goodwill (Details) (USD $)	Dec. 31, 2012	Dec. 31, 2012 OTC Healthcare	Dec. 31, 2012 Household Cleaning	Jun. 30, 2012 GSK Brands	Oct. 31, 2012 Sale of Phazyme Brand
Goodwill [Roll Forward]
Goodwill, gross, March 31, 2012	$ 369,032,000	$ 296,483,000	$ 72,549,000
Accumulated impairment losses, March 31, 2012	(195,330,000)	(130,170,000)	(65,160,000)
Goodwill, net, March 31, 2012	173,702,000	166,313,000	7,389,000
Additions	226,000	226,000	0
Reductions	(6,382,000)	(6,382,000)	0
Goodwill, gross, December 31, 2012	362,876,000	290,327,000	72,549,000
Accumulated impairment losses, December 31, 2012	(195,330,000)	(130,170,000)	(65,160,000)
Goodwill, net, December 31, 2012	167,546,000	160,157,000	7,389,000
Goodwill, Allocation Adjustment [Abstract]
Goodwill, post-closing inventory and apportionment adjustment				200,000
Discontinued Operations and Disposal Groups [Abstract]
Brand divested, sale price					$ 22,300,000

Intangible Assets (Details) (USD $)	0 Months Ended	3 Months Ended	9 Months Ended
Intangible Assets (Details) (USD $)	Oct. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Mar. 31, 2012
Indefinite-Lived Intangible Assets [Abstract]
Indefinite-lived intangibles, reductions			$ 0
Indefinite-lived intangibles, December 31, 2012		1,245,414,000	1,245,414,000
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions		3,100,000	8,980,000
Intangible Assets, Gross [Abstract]
Intangible assets, gross, March 31, 2012			1,463,084,000
Intangible assets, reductions			(16,142,000)
Intangible assets, gross, December 31, 2012		1,446,942,000	1,446,942,000
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, March 31, 2012			62,562,000
Intangible assets, accumulated amortization, additions		3,100,000	8,980,000
Intangible assets, accumulated amortization, reductions			(538,000)
Intangible assets, accumulated amortization, December 31, 2012		71,004,000	71,004,000
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net		130,524,000	130,524,000
Intangible Assets, Net [Abstract]
Intangible assets, reductions, net	15,600,000
Intangible assets, net (excluding goodwill)		1,375,938,000	1,375,938,000	1,400,522,000
Indefinite Lived Trademarks
Indefinite-Lived Intangible Assets [Abstract]
Indefinite-lived intangibles, March 31, 2012				1,245,414,000
Indefinite-lived intangibles, December 31, 2012		1,245,414,000	1,245,414,000	1,245,414,000
Finite Lived Trademarks
Finite-Lived Intangible Assets, Gross [Abstract]
Finite-lived intangibles, gross, March 31, 2012			217,512,000
Finite-lived intangibles, reductions			(16,142,000)
Finite-lived intangibles, gross, December 31, 2012		201,370,000	201,370,000
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite-lived intangibles, accumulated amortization, March 31, 2012			62,404,000
Intangible assets, accumulated amortization, additions			8,980,000
Finite-lived intangibles, accumulated amortization, reductions			(538,000)
Finite-lived intangibles, accumulated amortization, December 31, 2012		70,846,000	70,846,000
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions			8,980,000
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net		130,524,000	130,524,000
Noncompete Agreements
Finite-Lived Intangible Assets, Gross [Abstract]
Finite-lived intangibles, gross, March 31, 2012			158,000
Finite-lived intangibles, reductions			0
Finite-lived intangibles, gross, December 31, 2012		158,000	158,000
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite-lived intangibles, accumulated amortization, March 31, 2012			158,000
Intangible assets, accumulated amortization, additions			0
Finite-lived intangibles, accumulated amortization, reductions			0
Finite-lived intangibles, accumulated amortization, December 31, 2012		158,000	158,000
Intangible Assets, Accumulated Amortization [Abstract]
Intangible assets, accumulated amortization, additions			0
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net		0	0
Sale of Phazyme Brand
Schedule of Intangible Assets [Line Items]
Brand divested, sale price	$ 22,300,000

Intangible Assets (Expected Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average remaining period		13 years
Amortization of intangible assets	$ 3,100	$ 8,980
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2013 (Remaining three months ending March 31, 2013)	2,745	2,745
2014	10,175	10,175
2015	8,840	8,840
2016	8,840	8,840
2017	8,840	8,840
Thereafter	91,084	91,084
Intangible assets, net	$ 130,524	$ 130,524
Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives		3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives		30 years

Other Accrued Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2012	Mar. 31, 2012
Payables and Accruals [Abstract]
Accrued marketing costs	$ 23,151	$ 10,554
Accrued payroll	6,742	7,181
Accrued commissions	550	415
Accrued income taxes	0	577
Accrued professional fees	1,724	3,821
Deferred rent	1,091	9
Accrued severance	63	461
Accrued lease termination costs	951	290
Other accrued liabilities	$ 34,272	$ 23,308

Long-Term Debt (Narrative) (Details) (USD $)	0 Months Ended	9 Months Ended										0 Months Ended										0 Months Ended								9 Months Ended					0 Months Ended			0 Months Ended	1 Months Ended	3 Months Ended				9 Months Ended	12 Months Ended					9 Months Ended
Long-Term Debt (Narrative) (Details) (USD $)	Mar. 24, 2010	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012	Jan. 31, 2012	Nov. 01, 2010	Jan. 31, 2012 2012 Senior Notes	Jan. 31, 2012 Term Loan and ABL Revolver 2012	Dec. 31, 2012 Revolving Credit Facility 2010 Revolving Credit Facility	Nov. 01, 2010 Revolving Credit Facility 2010 Revolving Credit Facility	Mar. 24, 2010 Revolving Credit Facility 2010 Revolving Credit Facility	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver	Dec. 31, 2012 Revolving Credit Facility 2012 ABL Revolver	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR Minimum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver LIBOR Maximum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Minimum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Maximum	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate Federal Funds Rate	Jan. 31, 2012 Revolving Credit Facility 2012 ABL Revolver Base Rate LIBOR	Nov. 01, 2010 Senior Notes 2010 Senior Notes	Mar. 24, 2010 Senior Notes 2010 Senior Notes	Mar. 31, 2011 Senior Notes 2010 Senior Notes	Mar. 24, 2010 Senior Notes 2010 Senior Notes Prior To April 1, 2014	Mar. 24, 2010 Senior Notes 2010 Senior Notes Twelve Months Beginning April 1, 2014	Mar. 24, 2010 Senior Notes 2010 Senior Notes Twelve Months Beginning April 1, 2015	Mar. 24, 2010 Senior Notes 2010 Senior Notes On or After April 1, 2016	Mar. 24, 2010 Senior Notes 2010 Senior Notes Prior to April 1, 2013	Dec. 31, 2012 Senior Notes 2012 Senior Notes	Jan. 31, 2012 Senior Notes 2012 Senior Notes	Jan. 31, 2012 Senior Notes 2012 Senior Notes Prior To April 1, 2014	Jan. 31, 2012 Senior Notes 2012 Senior Notes Prior to April 1, 2013	Jan. 31, 2012 Senior Notes 2012 Senior Notes Upon Change in Control	Nov. 01, 2010 Term Loans 2010 Term Loan	Mar. 24, 2010 Term Loans 2010 Term Loan	Mar. 24, 2010 Term Loans 2010 Term Loan LIBOR	Jan. 31, 2012 Term Loans 2012 Term Loan	Mar. 31, 2012 Term Loans 2012 Term Loan	Dec. 31, 2012 Term Loans 2012 Term Loan	Sep. 30, 2012 Term Loans 2012 Term Loan	Jun. 30, 2012 Term Loans 2012 Term Loan	Mar. 31, 2012 Term Loans 2012 Term Loan	Dec. 31, 2012 Term Loans 2012 Term Loan	Mar. 31, 2012 Term Loans 2012 Term Loan	Jan. 31, 2012 Term Loans 2012 Term Loan LIBOR Minimum	Jan. 31, 2012 Term Loans 2012 Term Loan Base Rate	Jan. 31, 2012 Term Loans 2012 Term Loan Base Rate Federal Funds Rate	Jan. 31, 2012 Term Loans 2012 Term Loan Base Rate LIBOR	Dec. 31, 2012 Revolving Credit Facility 2012 ABL Revolver
Debt Instrument [Line Items]
Debt instrument, face amount																							$ 150,000,000								$ 250,000,000					$ 150,000,000		$ 660,000,000
Debt instrument, stated interest rate																							8.25%								8.125%
Debt instrument, increase, additional borrowings																						100,000,000													115,000,000
Debt instrument, unamortized discount		7,200,000		11,092,000																			2,200,000													1,800,000
Debt instrument, unamortized premium																						300,000
Proceeds from issuance of long-term debt																						100,300,000	147,800,000													148,200,000		650,100,000
Debt instrument, effective interest rate																								8.50%												5.00%
Percentage of subsidiary owned					100.00%
Accelerated amortization of deferred financing costs and original issue discounts																																								7,700,000
Accelerated amortization of deferred financing costs and original issue discounts, amount recorded in current period applicable to prior 3 months																																								3,000,000
Pro forma increase (decrease) to income if properly recorded in applicable period, pre-tax																																								3,000,000	(700,000)	(1,200,000)	(1,100,000)	1,100,000	1,100,000
Pro forma increase (decrease) to income if properly recorded in applicable period, after tax																																								1,900,000	(500,000)	(700,000)	(700,000)	700,000	700,000
Pro forma increase (decrease) to income if properly recorded in applicable period, per diluted share																																								$ 0.03	$ (0.01)	$ (0.02)	$ (0.01)	$ 0.01	$ 0.01
Debt instrument, basis spread on variable rate																																					3.25%									1.25%
Debt instrument, reference rate floor																																				1.50%
Line of credit facility, maximum borrowing capacity										40,000,000	30,000,000	50,000,000	75,000,000
Line of credit facility, increase in borrowing capacity									25,000,000	10,000,000
Debt instrument, discount, percentage																																						1.50%
Debt issuance costs capitalized	6,600,000					600,000	12,600,000	20,600,000				1,800,000																			12,600,000							18,800,000
Accelerated amortization of deferred financing costs																																								5,100,000
Debt instrument, maturity term												5 years																										7 years
Debt instrument, basis spread on variable rate, fixed component																				0.50%	1.00%																										2.25%	0.50%	1.00%
Debt instrument, average interest rate during period																																												5.40%
Debt instrument, quarterly payment, percent of original principal amount																																						0.25%
Repayments of long-term debt		167,500,000	58,000,000																											167,500,000									25,000,000					167,500,000
Debt instrument, variable rate														1.75%			0.75%
Debt instrument, conditional variable rate															2.00%	2.25%		1.00%	1.25%
Line of credit facility, commitment fee percentage												0.50%
Line of credit facility, conditional commitment fee percentage												0.375%
Line of credit facility, interest rate at period end													2.30%
Debt issuance costs	7,300,000
Debt issuance costs charged to expense	700,000
Debt instrument, redemption price, percentage of principal amount																									100.00%	104.125%	102.063%	100.00%	108.25%			100.00%	108.125%	101.00%
Debt instrument, percentage of principal amount eligible for redemption																													35.00%				35.00%
Line of credit facility, net amount borrowed in period																																																		40,000,000
Accelerated amortization of debt discount																																								$ 2,600,000

Long-Term Debt (Schedule of Long-term Debt) (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012	Mar. 24, 2010
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,007,500,000	$ 1,135,000,000
Current portion of long-term debt	0	0
Long-term debt, gross, excluding current maturities	1,007,500,000	1,135,000,000
Less: unamortized discount	(7,200,000)	(11,092,000)
Long-term debt, net of unamortized discount	1,000,300,000	1,123,908,000
Senior Notes \| 2012 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	250,000,000	250,000,000
Senior Notes \| 2010 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	250,000,000	250,000,000
Less: unamortized discount			(2,200,000)
Term Loans \| 2012 Term Loan
Debt Instrument [Line Items]
Long-term debt, gross	467,500,000	635,000,000
Revolving Credit Facility \| 2012 ABL Revolver
Debt Instrument [Line Items]
Long-term debt, gross	$ 40,000,000	$ 0

- Definition

Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date before deducting unamortized discount or premiums (if any). May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer.

+ References+ Details

- Definition

The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References+ Details

Long-Term Debt (Maturities of Long-term Debt) (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Debt Disclosure [Abstract]
2013 (remaining three months ending March 31, 2013)	$ 0
2014	0
2015	0
2016	0
2017	40,000,000
Thereafter	967,500,000
Long-term debt, gross	$ 1,007,500,000	$ 1,135,000,000

- Definition

+ References+ Details

Fair Value Measurements (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Senior Notes \| 2012 Senior Notes \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	$ 250,000,000	$ 250,000,000
Senior Notes \| 2010 Senior Notes \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	250,000,000	250,000,000
Senior Notes \| Fair Value, Measurements, Nonrecurring [Member] \| Fair Value, Inputs, Level 2 \| 2012 Senior Notes \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	278,100,000	270,600,000
Senior Notes \| Fair Value, Measurements, Nonrecurring [Member] \| Fair Value, Inputs, Level 2 \| 2010 Senior Notes \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	276,300,000	272,500,000
Term Loans \| 2012 Term Loan \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	467,500,000	635,000,000
Term Loans \| Fair Value, Measurements, Nonrecurring [Member] \| Fair Value, Inputs, Level 2 \| 2012 Term Loan \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans payable, fair value disclosure	472,200,000	639,000,000
Revolving Credit Facility \| 2012 ABL Revolver \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Line of credit, fair value disclosure	40,000,000
Revolving Credit Facility \| Fair Value, Measurements, Nonrecurring [Member] \| Fair Value, Inputs, Level 2 \| 2012 ABL Revolver \| Portion at Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Line of credit, fair value disclosure	$ 40,000,000

Stockholders' Equity (Details) (USD $)			3 Months Ended		9 Months Ended
Stockholders' Equity (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2012 Restricted Shares	Dec. 31, 2011 Restricted Shares	Dec. 31, 2012 Restricted Shares	Dec. 31, 2011 Restricted Shares
Class of Stock [Line Items]
Common stock, shares authorized	250,000,000	250,000,000
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Voting rights, number of votes per common share owned	1
Restricted stock repurchased during period, shares			0	0	0	20,999
Restricted stock acquired, average cost per share						$ 12.86

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

Accumulated Other Comprehensive Income (Loss) (Components of AOCI) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2012	Mar. 31, 2012
Accumulated Other Comprehensive Income [Abstract]
Cumulative translation adjustment	$ 10	$ (13)
Total accumulated other comprehensive loss	$ 10	$ (13)

- Definition

Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 17, 18, 19, 22, 23, 24, 25, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 31

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Earnings Per Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Numerator
Net income	$ 12,257	$ 9,510	$ 46,156	$ 37,227
Denominator
Denominator for basic earnings per share — weighted average shares outstanding (in shares)	50,686	50,307	50,465	50,256
Dilutive effect of unvested restricted common stock (including restricted stock units) and options issued to employees and directors (in shares)	837	377	820	411
Denominator for diluted earnings per share (in shares)	51,523	50,684	51,285	50,667
Earnings per Common Share:
Basic net earnings per share (in USD per share)	$ 0.24	$ 0.19	$ 0.91	$ 0.74
Diluted net earnings per share (in USD per share)	$ 0.24	$ 0.19	$ 0.90	$ 0.73

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=16381557&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References+ Details

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 171

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Earnings Per Share Antidilutive Securities (Details) (Outstanding Stock Awards [Member]) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Outstanding Stock Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares (fewer than 0.1 million shares for the three and nine months ended December 31, 2012)	0.1	0.7	0.1	0.5

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 171

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Share-Based Compensation (Narrative) (Details) (USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended		9 Months Ended								0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended
	May 09, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 Restricted Shares	Dec. 31, 2011 Restricted Shares	Dec. 31, 2012 Restricted Shares Minimum	Dec. 31, 2012 Restricted Shares Maximum	Dec. 31, 2012 Stock Options Minimum	Dec. 31, 2012 Stock Options Maximum	May 09, 2012 Employee Restricted Stock Units (RSUs)	Dec. 31, 2012 Employee Restricted Stock Units (RSUs)	Jun. 29, 2012 Director Restricted Stock Units (RSUs)	Dec. 31, 2012 Director Restricted Stock Units (RSUs)	Aug. 06, 2012 Executive Compensation Contracts	Aug. 06, 2012 Executive Compensation Contracts Restricted Stock Units (RSUs)	Aug. 06, 2012 Executive Compensation Contracts Stock Options	Aug. 06, 2012 Executive Compensation Contracts Stock Options Maximum	Aug. 06, 2012 Common Stock Executive Compensation Contracts Stock Options
Share-based Compensation, Aggregate Disclosures:
Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plan		5,000,000		5,000,000
Share-based compensation costs charged against income		$ 1.0	$ 0.7	$ 3.0	$ 2.4
Tax benefit recognized from share-based compensation expense		0.3	0.2	0.9	0.6
Award vesting period								3 years	5 years	3 years	5 years		3 years		1 year			3 years
Unrecognized compensation costs related to nonvested awards		4.0		4.0
Unrecognized compensation costs related to nonvested awards, weighted average period for recognition				10 months 24 days
Total fair value of vested shares				2.1	2.8
Shares available for issuance under the Plan		1,900,000		1,900,000
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock and Restricted Stock Units, Additional Disclosures [Abstract]
Restricted common stock units granted in period, shares						128,900	122,500					111,152		12,652			5,109
Granted, weighted-average grant-date fair value (in USD per share)						$ 13.59	$ 11.35
Options, Additional Disclosures:
Award exercisability period, from date of grant											10 years								10 years
Options granted, shares	422,962			444,900	308,100
Options granted, weighted-average exercise price (in USD per share)	$ 13.24			$ 13.36	$ 11.27
Common shares to be issued upon exercise																				21,978
Options granted, weighted-average grant-date fair value (in USD per share)				$ 6.03	$ 5.83											$ 15.66
Percentage of options vesting annually																33.30%
Options exercised, aggregate intrinsic value				8.8
Options granted, grant-date aggregate intrinsic value				3.0
Cash received from exercise of stock options				5.4	0.7
Tax benefit realized from exercise of stock options				$ 9.3	$ 0.1

Share-Based Compensation (Restricted Shares Activity) (Details) (Restricted Shares, USD $)	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning of period	363,400	275,400
Granted	128,900	122,500
Vested and issued	(27,000)	(103,400)
Forfeited	(12,300)	(15,200)
Outstanding, end of period	453,000	279,300
Vested, end of period	70,400	54,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)	$ 9.92	$ 8.46
Granted, weighted-average grant-date fair value (in USD per share)	$ 13.59	$ 11.35
Vested and issued, weighted-average grant-date fair value (in USD per share)	$ 7.16	$ 9.93
Forfeited, weighted-average grant-date fair value (in USD per share)	$ 10.69	$ 10.72
Outstanding, end of period, weighted-average grant-date fair value (in USD per share)	$ 11.11	$ 9.06
Vested, end of period, weighted-average grant-date fair value (in USD per share)	$ 8.52	$ 7.40

Share-Based Compensation (Stock Option Valuation Assumptions) (Details) (Stock Options, USD $)	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	43.99%	53.00%
Expected dividends	$ 0	$ 0
Expected term in years	6 years 6 months	6 years 6 months
Risk-free rate	1.20%	2.40%

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References+ Details

Share-Based Compensation (Stock Option Activity) (Details) (USD $) In Thousands, except Share data, unless otherwise specified	0 Months Ended	9 Months Ended
	May 09, 2012	Dec. 31, 2012	Dec. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options granted, weighted-average grant-date fair value (in USD per share)		$ 6.03	$ 5.83
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of period		1,745,400	1,621,500
Granted	422,962	444,900	308,100
Exercised		(708,500)	(54,200)
Forfeited or expired		(17,400)	(78,900)
Outstanding, end of period		1,464,400	1,796,500
Exercisable, end of period		332,400	678,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding, beginning of period, weighted-average exercise price (in USD per share)		$ 8.44	$ 8.19
Granted, weighted-average exercise price (in USD per share)	$ 13.24	$ 13.36	$ 11.27
Exercised, weighted-average exercise price (in USD per share)		$ 7.71	$ 10.54
Forfeited or expired, weighted-average exercise price (in USD per share)		$ 11.21	$ 11.93
Outstanding, end of period, weighted-average exercise price (in USD per share)		$ 10.26	$ 8.48
Exercisable, end of period, weighted-average exercise price (in USD per share)		$ 9.99	$ 8.43
Options, Additional Disclosures:
Outstanding, end of period, weighted-average remaining contractual term		7 years 7 months 30 days	7 years 10 months 29 days
Exercisable, end of period, weighted-average remaining contractual term		6 years 10 months 1 day	7 years 4 months 26 days
Outstanding, end of period, aggregate intrinsic value		$ 11,330	$ 5,125
Exercisable, end of period, aggregate intrinsic value		$ 2,248	$ 2,035

Income Taxes (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012
Income Tax Disclosure [Abstract]
Effective income tax rate	38.90%	38.70%	38.90%	38.30%
Net operating loss carryforwards	$ 1.2		$ 1.2
Operating loss carryforwards, limitation on use, annual amount	0.2		0.2
Uncertain tax liability	$ 0.2		$ 0.2		$ 0.3

- Definition

A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.

+ References+ Details

Commitments and Contingencies (Future Minimum Rental Payments) (Details) (USD $)	3 Months Ended		9 Months Ended			3 Months Ended	1 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 Office Facilities	Dec. 31, 2012 New York	May 31, 2012 Arkansas	Dec. 31, 2012 Equipment
Operating Leased Assets [Line Items]
Operating lease, term						5 years 6 months	3 years
2013 (Remaining three months ending March 31, 2013)	$ 311,000		$ 311,000		$ 275,000			$ 36,000
2014	1,905,000		1,905,000		1,764,000			141,000
2015	1,185,000		1,185,000		1,049,000			136,000
2016	1,129,000		1,129,000		994,000			135,000
2017	1,091,000		1,091,000		1,023,000			68,000
Thereafter	1,044,000		1,044,000		1,044,000			0
Total future minimum payments due	6,665,000		6,665,000		6,149,000			516,000
Operating leases, rent expense	$ 300,000	$ 200,000	$ 900,000	$ 700,000

Commitments and Contingencies (Long-term Supply Agreement) (Details) (USD $)	9 Months Ended
	Dec. 31, 2012
Long-term Purchase Commitment [Line Items]
Short-term supply arrangement	$ 3,200,000
Third-party Manufacturing
Long-term Purchase Commitment [Line Items]
Supply agreement, term	10 years
2013 (Remaining three months ending March 31, 2013)	3,460,000
2014	1,136,000
2015	1,105,000
2016	1,074,000
2017	1,044,000
Thereafter	2,555,000
Total purchase commitment	$ 10,374,000

Concentrations of Risk (Details)	3 Months Ended		9 Months Ended
Concentrations of Risk (Details)	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 brand	Dec. 31, 2011
Concentration Risk [Line Items]
Number of third-party manufacturers	62	52	62	52
Sales \| Product Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	40.30%	55.00%	40.70%	54.80%
Number of highest selling brands comprising group against which concentration risk is measured			5
Sales \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	15.30%	20.90%	16.60%	19.10%
Number of customers exceeding concentration risk benchmark	1	1	1	1
Sales \| Supplier Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage			77.10%	66.70%
Number of third-party manufacturers with long-term contracts			24	15
Accounts Receivable \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage			23.60%

Business Segments (Information on Operating and Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information, Profit (Loss):
Net sales	$ 159,492	$ 105,799	$ 466,735	$ 304,678
Other revenues	740	451	2,349	2,411
Total revenues	160,232	106,250	469,084	307,089
Cost of sales	75,235	51,128	209,938	148,193
Gross profit	84,997	55,122	259,146	158,896
Advertising and promotion	23,538	15,274	67,371	38,580
Contribution margin	61,459	39,848	191,775	120,316
Other operating expenses	14,737	16,218	50,064	40,049
Operating income	46,722	23,630	141,711	80,267
Other expense	26,661	8,116	66,169	19,910
Income before income taxes	20,061	15,514	75,542	60,357
Provision for income taxes	7,804	6,004	29,386	23,130
Net income	12,257	9,510	46,156	37,227
OTC Healthcare
Segment Reporting Information, Profit (Loss):
Net sales	138,858	84,711	402,633	234,712
Other revenues	175	195	520	552
Total revenues	139,033	84,906	403,153	235,264
Cost of sales	59,381	35,329	160,249	97,198
Gross profit	79,652	49,577	242,904	138,066
Advertising and promotion	22,410	14,170	62,309	34,746
Contribution margin	57,242	35,407	180,595	103,320
Household Cleaning
Segment Reporting Information, Profit (Loss):
Net sales	20,634	21,088	64,102	69,966
Other revenues	565	256	1,829	1,859
Total revenues	21,199	21,344	65,931	71,825
Cost of sales	15,854	15,799	49,689	50,995
Gross profit	5,345	5,545	16,242	20,830
Advertising and promotion	1,128	1,104	5,062	3,834
Contribution margin	$ 4,217	$ 4,441	$ 11,180	$ 16,996
Geographic Concentration Risk \| Sales \| United States and Canada
Geographic Areas, Revenues from External Customers [Abstract]
Concentration risk, percentage	97.20%	96.20%	97.40%	96.30%
Customer Concentration Risk \| Sales
Geographic Areas, Revenues from External Customers [Abstract]
Concentration risk, percentage	15.30%	20.90%	16.60%	19.10%

Business Segments (Revenue by Product) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Revenue from External Customer [Line Items]
Revenues	$ 160,232	$ 106,250	$ 469,084	$ 307,089
OTC Healthcare
Revenue from External Customer [Line Items]
Revenues	139,033	84,906	403,153	235,264
OTC Healthcare \| Analgesics
Revenue from External Customer [Line Items]
Revenues	27,946	597	81,727	1,955
OTC Healthcare \| Cough & Cold
Revenue from External Customer [Line Items]
Revenues	37,424	40,621	94,197	89,858
OTC Healthcare \| Gastrointestinal
Revenue from External Customer [Line Items]
Revenues	24,977	3,480	74,510	13,924
OTC Healthcare \| Eye & Ear Care
Revenue from External Customer [Line Items]
Revenues	19,702	17,091	63,109	53,940
OTC Healthcare \| Dermatologicals
Revenue from External Customer [Line Items]
Revenues	11,496	10,580	41,578	39,060
OTC Healthcare \| Oral Care
Revenue from External Customer [Line Items]
Revenues	12,953	11,501	36,032	33,712
OTC Healthcare \| Other OTC
Revenue from External Customer [Line Items]
Revenues	4,535	1,036	12,000	2,815
Household Cleaning
Revenue from External Customer [Line Items]
Revenues	$ 21,199	$ 21,344	$ 65,931	$ 71,825

Business Segments (Assets by Segment) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2012	Mar. 31, 2012
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	$ 167,546	$ 173,702
Indefinite-lived intangibles	1,245,414
Finite-lived intangibles	130,524
Intangible assets, net (excluding goodwill)	1,375,938	1,400,522
Intangible assets, net (including goodwill)	1,543,484
OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	160,157	166,313
Indefinite-lived intangibles	1,125,594
Finite-lived intangibles	102,177
Intangible assets, net (excluding goodwill)	1,227,771
Intangible assets, net (including goodwill)	1,387,928
Household Cleaning
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	7,389	7,389
Indefinite-lived intangibles	119,820
Finite-lived intangibles	28,347
Intangible assets, net (excluding goodwill)	148,167
Intangible assets, net (including goodwill)	$ 155,556

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Gain on Settlement (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
Gain on Settlement (Details) (USD $)	Jun. 15, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Loss Contingencies [Line Items]
Proceeds from settlement of pending litigation	$ 8,000,000
Litigation settlement, costs incurred					2,900,000
Gain on settlement		0	0	0	5,063,000
Gain on settlement, net of tax					3,200,000
Individual Counterparty
Loss Contingencies [Line Items]
Number of defendants	2
Other (Income) Expense
Loss Contingencies [Line Items]
Gain on settlement					$ 5,063,000

Condensed Consolidating Financial Statements (Condensed Consolidating Statements of Income and Comprehensive Income) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Revenues
Net sales	$ 159,492	$ 105,799	$ 466,735	$ 304,678
Other revenues	740	451	2,349	2,411
Total revenues	160,232	106,250	469,084	307,089
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	75,235	51,128	209,938	148,193
Gross profit	84,997	55,122	259,146	158,896
Operating Expenses
Advertising and promotion	23,538	15,274	67,371	38,580
General and administrative	11,378	13,655	40,114	32,366
Depreciation and amortization	3,359	2,563	9,950	7,683
Total operating expenses	38,275	31,492	117,435	78,629
Operating income	46,722	23,630	141,711	80,267
Other (income) expense
Interest income	(4)	(1)	(9)	(4)
Interest expense	26,665	8,117	66,178	24,977
Gain on settlement	0	0	0	(5,063)
Equity in income of subsidiaries	0	0	0	0
Total other expense	(26,661)	(8,116)	(66,169)	(19,910)
Income before income taxes	20,061	15,514	75,542	60,357
Provision for income taxes	7,804	6,004	29,386	23,130
Net income	12,257	9,510	46,156	37,227
Comprehensive income, net of tax:
Currency translation adjustments	(1)	(18)	23	(70)
Total other comprehensive income (loss)	(1)	(18)	23	(70)
Comprehensive income	12,256	9,492	46,179	37,157
Prestige Brands Holdings, Inc.
Revenues
Net sales	0	0	0	0
Other revenues	0	0	0	0
Total revenues	0	0	0	0
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	0	0	0	0
Gross profit	0	0	0	0
Operating Expenses
Advertising and promotion	0	3	0	3
General and administrative	952	5,318	3,676	5,514
Depreciation and amortization	549	135	818	412
Total operating expenses	1,501	5,456	4,494	5,929
Operating income	(1,501)	(5,456)	(4,494)	(5,929)
Other (income) expense
Interest income	33	(12,302)	(24,337)	(38,196)
Interest expense	8,735	8,791	26,147	26,323
Gain on settlement				(5,063)
Equity in income of subsidiaries	(18,531)	(10,727)	(50,008)	(30,438)
Total other expense	9,763	14,238	48,198	47,374
Income before income taxes	8,262	8,782	43,704	41,445
Provision for income taxes	(3,995)	(728)	(2,452)	4,218
Net income	12,257	9,510	46,156	37,227
Comprehensive income, net of tax:
Currency translation adjustments	(1)	(18)	23	(70)
Total other comprehensive income (loss)	(1)	(18)	23	(70)
Comprehensive income	12,256	9,492	46,179	37,157
Prestige Brands, Inc., the issuer
Revenues
Net sales	25,345	27,352	75,294	74,767
Other revenues	79	57	220	178
Total revenues	25,424	27,409	75,514	74,945
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	9,877	9,784	28,493	27,191
Gross profit	15,547	17,625	47,021	47,754
Operating Expenses
Advertising and promotion	3,032	3,431	8,917	9,341
General and administrative	1,585	2,322	5,020	7,502
Depreciation and amortization	140	143	420	428
Total operating expenses	4,757	5,896	14,357	17,271
Operating income	10,790	11,729	32,664	30,483
Other (income) expense
Interest income	(41,552)	(11,118)	(63,573)	(33,291)
Interest expense	35,394	16,907	92,320	51,299
Gain on settlement				0
Equity in income of subsidiaries	(8,407)	(7,936)	(49,280)	(23,768)
Total other expense	14,565	2,147	20,533	5,760
Income before income taxes	25,355	13,876	53,197	36,243
Provision for income taxes	6,593	2,285	1,524	4,781
Net income	18,762	11,591	51,673	31,462
Comprehensive income, net of tax:
Currency translation adjustments	0	0	0	0
Total other comprehensive income (loss)	0	0	0	0
Comprehensive income	18,762	11,591	51,673	31,462
Combined Subsidiary Guarantors
Revenues
Net sales	132,881	77,308	387,815	226,859
Other revenues	724	451	2,310	2,386
Total revenues	133,605	77,759	390,125	229,245
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	65,172	41,154	181,382	121,032
Gross profit	68,433	36,605	208,743	108,213
Operating Expenses
Advertising and promotion	19,997	11,216	57,326	28,133
General and administrative	8,734	5,684	30,802	18,538
Depreciation and amortization	2,658	2,267	8,667	6,789
Total operating expenses	31,389	19,167	96,795	53,460
Operating income	37,044	17,438	111,948	54,753
Other (income) expense
Interest income	162	0	162	0
Interest expense	23,951	5,898	35,613	19,011
Gain on settlement				0
Equity in income of subsidiaries	(393)	39	(1,306)	(745)
Total other expense	(23,720)	(5,937)	(34,469)	(18,266)
Income before income taxes	13,324	11,501	77,479	36,487
Provision for income taxes	5,030	4,454	29,631	13,697
Net income	8,294	7,047	47,848	22,790
Comprehensive income, net of tax:
Currency translation adjustments	0	0	0	0
Total other comprehensive income (loss)	0	0	0	0
Comprehensive income	8,294	7,047	47,848	22,790
Combined Non-Guarantor Subsidiaries
Revenues
Net sales	1,266	1,139	3,626	3,052
Other revenues	276	227	1,270	1,131
Total revenues	1,542	1,366	4,896	4,183
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	525	474	1,514	1,254
Gross profit	1,017	892	3,382	2,929
Operating Expenses
Advertising and promotion	509	624	1,128	1,103
General and administrative	107	331	616	812
Depreciation and amortization	12	18	45	54
Total operating expenses	628	973	1,789	1,969
Operating income	389	(81)	1,593	960
Other (income) expense
Interest income	(62)	(60)	(163)	(173)
Interest expense	0	0	0	0
Gain on settlement				0
Equity in income of subsidiaries	0	0	0	0
Total other expense	62	60	163	173
Income before income taxes	451	(21)	1,756	1,133
Provision for income taxes	176	(7)	683	434
Net income	275	(14)	1,073	699
Comprehensive income, net of tax:
Currency translation adjustments	1	(18)	(23)	(70)
Total other comprehensive income (loss)	1	(18)	(23)	(70)
Comprehensive income	276	(32)	1,050	629
Eliminations
Revenues
Net sales	0	0	0	0
Other revenues	(339)	(284)	(1,451)	(1,284)
Total revenues	(339)	(284)	(1,451)	(1,284)
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	(339)	(284)	(1,451)	(1,284)
Gross profit	0	0	0	0
Operating Expenses
Advertising and promotion	0	0	0	0
General and administrative	0	0	0	0
Depreciation and amortization	0	0	0	0
Total operating expenses	0	0	0	0
Operating income	0	0	0	0
Other (income) expense
Interest income	41,415	23,479	87,902	71,656
Interest expense	(41,415)	(23,479)	(87,902)	(71,656)
Gain on settlement				0
Equity in income of subsidiaries	27,331	18,624	100,594	54,951
Total other expense	(27,331)	(18,624)	(100,594)	(54,951)
Income before income taxes	(27,331)	(18,624)	(100,594)	(54,951)
Provision for income taxes	0	0	0	0
Net income	(27,331)	(18,624)	(100,594)	(54,951)
Comprehensive income, net of tax:
Currency translation adjustments	(1)	18	23	70
Total other comprehensive income (loss)	(1)	18	23	70
Comprehensive income	$ (27,332)	$ (18,606)	$ (100,571)	$ (54,881)

Condensed Consolidating Financial Statements (Condensed Consolidating Balance Sheet) (Details) (USD $)	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2011	Mar. 31, 2011
Current assets
Cash and cash equivalents	$ 10,431,000	$ 19,015,000	$ 4,439,000	$ 13,334,000
Accounts receivable, net	73,752,000	60,228,000
Inventories	54,250,000	51,113,000
Deferred income tax assets	6,594,000	5,283,000
Prepaid expenses and other current assets	6,195,000	11,396,000
Total current assets	151,222,000	147,035,000
Property and equipment, net	9,190,000	1,304,000
Goodwill	167,546,000	173,702,000
Intangible assets, net	1,375,938,000	1,400,522,000
Other long-term assets	27,493,000	35,713,000
Intercompany receivable	0	0
Investment in subsidiary	0	0
Total Assets	1,731,389,000	1,758,276,000
Current liabilities
Accounts payable	40,858,000	26,726,000
Accrued interest payable	13,620,000	13,889,000
Other accrued liabilities	34,272,000	23,308,000
Total current liabilities	88,750,000	63,923,000
Long-term debt
Principal amount	1,007,500,000	1,135,000,000
Less unamortized discount	(7,200,000)	(11,092,000)
Long-term debt, net of unamortized discount	1,000,300,000	1,123,908,000
Deferred income tax liabilities	185,007,000	167,717,000
Intercompany payable	0	0
Total Liabilities	1,274,057,000	1,355,548,000
Stockholders' Equity
Preferred share rights	283,000	283,000
Common stock	512,000	505,000
Additional paid-in capital	400,316,000	391,898,000
Treasury stock, at cost - 181 shares	(687,000)	(687,000)
Accumulated other comprehensive income (loss), net of tax	10,000	(13,000)
Retained earnings (accumulated deficit)	56,898,000	10,742,000
Total Stockholders' Equity	457,332,000	402,728,000
Total Liabilities and Stockholders' Equity	1,731,389,000	1,758,276,000
Prestige Brands Holdings, Inc.
Current assets
Cash and cash equivalents	8,878,000	18,221,000	3,545,000	12,698,000
Accounts receivable, net	140,000	25,000
Inventories	0	0
Deferred income tax assets	213,000	356,000
Prepaid expenses and other current assets	1,656,000	8,102,000
Total current assets	10,887,000	26,704,000
Property and equipment, net	8,987,000	934,000
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivable	1,284,415,000	680,067,000
Investment in subsidiary	808,377,000	1,358,120,000
Total Assets	2,112,666,000	2,065,825,000
Current liabilities
Accounts payable	2,275,000	4,531,000
Accrued interest payable	0	0
Other accrued liabilities	10,571,000	11,758,000
Total current liabilities	12,846,000	16,289,000
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	0	0
Intercompany payable	1,642,488,000	1,646,808,000
Total Liabilities	1,655,334,000	1,663,097,000
Stockholders' Equity
Preferred share rights	283,000	283,000
Common stock	512,000	505,000
Additional paid-in capital	400,316,000	391,898,000
Treasury stock, at cost - 181 shares	(687,000)	(687,000)
Accumulated other comprehensive income (loss), net of tax	10,000	(13,000)
Retained earnings (accumulated deficit)	56,898,000	10,742,000
Total Stockholders' Equity	457,332,000	402,728,000
Total Liabilities and Stockholders' Equity	2,112,666,000	2,065,825,000
Prestige Brands, Inc., the issuer
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	13,217,000	13,502,000
Inventories	9,340,000	8,098,000
Deferred income tax assets	730,000	849,000
Prepaid expenses and other current assets	425,000	56,000
Total current assets	23,712,000	22,505,000
Property and equipment, net	25,000	22,000
Goodwill	66,007,000	66,007,000
Intangible assets, net	193,530,000	193,932,000
Other long-term assets	27,493,000	35,713,000
Intercompany receivable	1,933,896,000	1,449,005,000
Investment in subsidiary	622,107,000	1,172,601,000
Total Assets	2,866,770,000	2,939,785,000
Current liabilities
Accounts payable	7,304,000	4,816,000
Accrued interest payable	13,620,000	13,889,000
Other accrued liabilities	2,485,000	1,687,000
Total current liabilities	23,409,000	20,392,000
Long-term debt
Principal amount	1,007,500,000	1,135,000,000
Less unamortized discount	(7,200,000)	(11,092,000)
Long-term debt, net of unamortized discount	1,000,300,000	1,123,908,000
Deferred income tax liabilities	50,869,000	50,944,000
Intercompany payable	451,454,000	455,702,000
Total Liabilities	1,526,032,000	1,650,946,000
Stockholders' Equity
Preferred share rights	0	0
Common stock	0	0
Additional paid-in capital	1,280,945,000	1,280,719,000
Treasury stock, at cost - 181 shares	0	0
Accumulated other comprehensive income (loss), net of tax	0	0
Retained earnings (accumulated deficit)	59,793,000	8,120,000
Total Stockholders' Equity	1,340,738,000	1,288,839,000
Total Liabilities and Stockholders' Equity	2,866,770,000	2,939,785,000
Combined Subsidiary Guarantors
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	59,428,000	45,954,000
Inventories	44,218,000	42,334,000
Deferred income tax assets	5,651,000	4,078,000
Prepaid expenses and other current assets	4,101,000	2,874,000
Total current assets	113,398,000	95,240,000
Property and equipment, net	178,000	346,000
Goodwill	101,539,000	107,695,000
Intangible assets, net	1,182,074,000	1,206,213,000
Other long-term assets	0	0
Intercompany receivable	420,375,000	314,699,000
Investment in subsidiary	6,890,000	5,583,000
Total Assets	1,824,454,000	1,729,776,000
Current liabilities
Accounts payable	30,012,000	17,008,000
Accrued interest payable	0	0
Other accrued liabilities	19,958,000	8,944,000
Total current liabilities	49,970,000	25,952,000
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	134,059,000	116,690,000
Intercompany payable	1,552,100,000	346,884,000
Total Liabilities	1,736,129,000	489,526,000
Stockholders' Equity
Preferred share rights	0	0
Common stock	0	0
Additional paid-in capital	39,724,000	1,239,497,000
Treasury stock, at cost - 181 shares	0	0
Accumulated other comprehensive income (loss), net of tax	0	0
Retained earnings (accumulated deficit)	48,601,000	753,000
Total Stockholders' Equity	88,325,000	1,240,250,000
Total Liabilities and Stockholders' Equity	1,824,454,000	1,729,776,000
Combined Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	1,553,000	794,000	894,000	636,000
Accounts receivable, net	967,000	747,000
Inventories	692,000	681,000
Deferred income tax assets	0	0
Prepaid expenses and other current assets	13,000	364,000
Total current assets	3,225,000	2,586,000
Property and equipment, net	0	2,000
Goodwill	0	0
Intangible assets, net	334,000	377,000
Other long-term assets	0	0
Intercompany receivable	7,537,000	5,935,000
Investment in subsidiary	0	0
Total Assets	11,096,000	8,900,000
Current liabilities
Accounts payable	1,267,000	371,000
Accrued interest payable	0	0
Other accrued liabilities	1,258,000	919,000
Total current liabilities	2,525,000	1,290,000
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	79,000	83,000
Intercompany payable	181,000	312,000
Total Liabilities	2,785,000	1,685,000
Stockholders' Equity
Preferred share rights	0	0
Common stock	0	0
Additional paid-in capital	1,111,000	1,111,000
Treasury stock, at cost - 181 shares	0	0
Accumulated other comprehensive income (loss), net of tax	10,000	(13,000)
Retained earnings (accumulated deficit)	7,190,000	6,117,000
Total Stockholders' Equity	8,311,000	7,215,000
Total Liabilities and Stockholders' Equity	11,096,000	8,900,000
Eliminations
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Inventories	0	0
Deferred income tax assets	0	0
Prepaid expenses and other current assets	0	0
Total current assets	0	0
Property and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivable	(3,646,223,000)	(2,449,706,000)
Investment in subsidiary	(1,437,374,000)	(2,536,304,000)
Total Assets	(5,083,597,000)	(4,986,010,000)
Current liabilities
Accounts payable	0	0
Accrued interest payable	0	0
Other accrued liabilities	0	0
Total current liabilities	0	0
Long-term debt
Principal amount	0	0
Less unamortized discount	0	0
Long-term debt, net of unamortized discount	0	0
Deferred income tax liabilities	0	0
Intercompany payable	(3,646,223,000)	(2,449,706,000)
Total Liabilities	(3,646,223,000)	(2,449,706,000)
Stockholders' Equity
Preferred share rights	0	0
Common stock	0	0
Additional paid-in capital	(1,321,780,000)	(2,521,327,000)
Treasury stock, at cost - 181 shares	0	0
Accumulated other comprehensive income (loss), net of tax	(10,000)	13,000
Retained earnings (accumulated deficit)	(115,584,000)	(14,990,000)
Total Stockholders' Equity	(1,437,374,000)	(2,536,304,000)
Total Liabilities and Stockholders' Equity	$ (5,083,597,000)	$ (4,986,010,000)

Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Operating Activities
Net income	$ 46,156	$ 37,227
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	9,950	7,683
Deferred income taxes	15,979	7,321
Amortization of deferred financing costs	8,220	847
Stock-based compensation costs	2,965	2,360
Lease termination costs	975	0
Amortization of debt discount	3,892	687
Loss on disposal of equipment	51	0
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(13,518)	(5,816)
Inventories	(3,351)	(3,850)
Prepaid expenses and other current assets	5,801	2,650
Accounts payable	14,125	2,392
Accrued liabilities	9,631	(3,508)
Net cash provided by operating activities	100,876	47,993
Investing Activities
Purchases of property and equipment	(8,922)	(358)
Proceeds from escrow of Blacksmith acquisition	0	1,200
Proceeds from the sale of property and equipment	15	0
Proceeds from the sale of the Phazyme brand	21,700	0
Acquisition of brands from GSK purchase price adjustments	(226)	0
Intercompany activity, net	0	0
Net cash provided by investing activities	12,567	842
Financing Activities
Repayments of long-term debt	(167,500)	(58,000)
Repayments under revolving credit agreement	(8,000)	0
Borrowings under revolving credit agreement	48,000	0
Proceeds from exercise of stock options	5,460	572
Shares surrendered as payment of tax withholding	0	(271)
Intercompany activity, net	0	0
Net cash used in financing activities	(122,040)	(57,699)
Effects of exchange rate changes on cash and cash equivalents	13	(31)
Decrease in cash and cash equivalents	(8,584)	(8,895)
Cash and cash equivalents - beginning of period	19,015	13,334
Cash and cash equivalents - end of period	10,431	4,439
Prestige Brands Holdings, Inc.
Operating Activities
Net income	46,156	37,227
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	818	412
Deferred income taxes	143	427
Amortization of deferred financing costs	0	0
Stock-based compensation costs	2,965	2,360
Lease termination costs	975
Amortization of debt discount	0	0
Loss on disposal of equipment	30
Equity in income of subsidiaries	(50,008)	(30,438)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(115)	(23)
Inventories	0	0
Prepaid expenses and other current assets	6,446	3,219
Accounts payable	(3,347)	(31)
Accrued liabilities	(1,071)	589
Net cash provided by operating activities	2,992	13,742
Investing Activities
Purchases of property and equipment	(8,922)	(140)
Proceeds from escrow of Blacksmith acquisition		0
Proceeds from the sale of property and equipment	0
Proceeds from the sale of the Phazyme brand	0
Acquisition of brands from GSK purchase price adjustments	0
Intercompany activity, net	(226)	1,200
Net cash provided by investing activities	(9,148)	1,060
Financing Activities
Repayments of long-term debt	0	0
Repayments under revolving credit agreement	0
Borrowings under revolving credit agreement	0
Proceeds from exercise of stock options	5,460	572
Shares surrendered as payment of tax withholding		(271)
Intercompany activity, net	(8,647)	(24,256)
Net cash used in financing activities	(3,187)	(23,955)
Effects of exchange rate changes on cash and cash equivalents	0	0
Decrease in cash and cash equivalents	(9,343)	(9,153)
Cash and cash equivalents - beginning of period	18,221	12,698
Cash and cash equivalents - end of period	8,878	3,545
Prestige Brands, Inc., the issuer
Operating Activities
Net income	51,673	31,462
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	420	428
Deferred income taxes	44	1,612
Amortization of deferred financing costs	8,220	847
Stock-based compensation costs	0	0
Lease termination costs	0
Amortization of debt discount	3,892	687
Loss on disposal of equipment	0
Equity in income of subsidiaries	(49,280)	(23,768)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	285	(2,930)
Inventories	(1,242)	(1,053)
Prepaid expenses and other current assets	(369)	(138)
Accounts payable	2,488	(502)
Accrued liabilities	529	(5,032)
Net cash provided by operating activities	16,660	1,613
Investing Activities
Purchases of property and equipment	0	0
Proceeds from escrow of Blacksmith acquisition		0
Proceeds from the sale of property and equipment	0
Proceeds from the sale of the Phazyme brand	0
Acquisition of brands from GSK purchase price adjustments	0
Intercompany activity, net	0	0
Net cash provided by investing activities	0	0
Financing Activities
Repayments of long-term debt	(167,500)	(58,000)
Repayments under revolving credit agreement	(8,000)
Borrowings under revolving credit agreement	48,000
Proceeds from exercise of stock options	0	0
Shares surrendered as payment of tax withholding		0
Intercompany activity, net	110,840	56,387
Net cash used in financing activities	(16,660)	(1,613)
Effects of exchange rate changes on cash and cash equivalents	0	0
Decrease in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Combined Subsidiary Guarantors
Operating Activities
Net income	47,848	22,790
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	8,667	6,789
Deferred income taxes	15,796	5,293
Amortization of deferred financing costs	0	0
Stock-based compensation costs	0	0
Lease termination costs	0
Amortization of debt discount	0	0
Loss on disposal of equipment	21
Equity in income of subsidiaries	(1,306)	(745)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(13,474)	(2,671)
Inventories	(2,104)	(2,822)
Prepaid expenses and other current assets	(627)	(418)
Accounts payable	14,095	2,571
Accrued liabilities	9,830	761
Net cash provided by operating activities	78,746	31,548
Investing Activities
Purchases of property and equipment	0	(218)
Proceeds from escrow of Blacksmith acquisition		1,200
Proceeds from the sale of property and equipment	15
Proceeds from the sale of the Phazyme brand	21,700
Acquisition of brands from GSK purchase price adjustments	(226)
Intercompany activity, net	226	(1,200)
Net cash provided by investing activities	21,715	(218)
Financing Activities
Repayments of long-term debt	0	0
Repayments under revolving credit agreement	0
Borrowings under revolving credit agreement	0
Proceeds from exercise of stock options	0	0
Shares surrendered as payment of tax withholding		0
Intercompany activity, net	(100,461)	(31,330)
Net cash used in financing activities	(100,461)	(31,330)
Effects of exchange rate changes on cash and cash equivalents	0	0
Decrease in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Combined Non-Guarantor Subsidiaries
Operating Activities
Net income	1,073	699
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	45	54
Deferred income taxes	(4)	(11)
Amortization of deferred financing costs	0	0
Stock-based compensation costs	0	0
Lease termination costs	0
Amortization of debt discount	0	0
Loss on disposal of equipment	0
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(214)	(192)
Inventories	(5)	25
Prepaid expenses and other current assets	351	(13)
Accounts payable	889	354
Accrued liabilities	343	174
Net cash provided by operating activities	2,478	1,090
Investing Activities
Purchases of property and equipment	0	0
Proceeds from escrow of Blacksmith acquisition		0
Proceeds from the sale of property and equipment	0
Proceeds from the sale of the Phazyme brand	0
Acquisition of brands from GSK purchase price adjustments	0
Intercompany activity, net	0	0
Net cash provided by investing activities	0	0
Financing Activities
Repayments of long-term debt	0	0
Repayments under revolving credit agreement	0
Borrowings under revolving credit agreement	0
Proceeds from exercise of stock options	0	0
Shares surrendered as payment of tax withholding		0
Intercompany activity, net	(1,732)	(801)
Net cash used in financing activities	(1,732)	(801)
Effects of exchange rate changes on cash and cash equivalents	13	(31)
Decrease in cash and cash equivalents	759	258
Cash and cash equivalents - beginning of period	794	636
Cash and cash equivalents - end of period	1,553	894
Eliminations
Operating Activities
Net income	(100,594)	(54,951)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	0	0
Deferred income taxes	0	0
Amortization of deferred financing costs	0	0
Stock-based compensation costs	0	0
Lease termination costs	0
Amortization of debt discount	0	0
Loss on disposal of equipment	0
Equity in income of subsidiaries	100,594	54,951
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	0	0
Inventories	0	0
Prepaid expenses and other current assets	0	0
Accounts payable	0	0
Accrued liabilities	0	0
Net cash provided by operating activities	0	0
Investing Activities
Purchases of property and equipment	0	0
Proceeds from escrow of Blacksmith acquisition		0
Proceeds from the sale of property and equipment	0
Proceeds from the sale of the Phazyme brand	0
Acquisition of brands from GSK purchase price adjustments	0
Intercompany activity, net	0	0
Net cash provided by investing activities	0	0
Financing Activities
Repayments of long-term debt	0	0
Repayments under revolving credit agreement	0
Borrowings under revolving credit agreement	0
Proceeds from exercise of stock options	0	0
Shares surrendered as payment of tax withholding		0
Intercompany activity, net	0	0
Net cash used in financing activities	0	0
Effects of exchange rate changes on cash and cash equivalents	0	0
Decrease in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	$ 0	$ 0

Condensed Consolidating Financial Statements (Revisions) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended			3 Months Ended		9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended			9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended			9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012	Dec. 31, 2012 Prestige Brands Holdings, Inc.	Dec. 31, 2011 Prestige Brands Holdings, Inc.	Dec. 31, 2012 Prestige Brands Holdings, Inc.	Dec. 31, 2011 Prestige Brands Holdings, Inc.	Mar. 31, 2012 Prestige Brands Holdings, Inc.	Dec. 31, 2012 Prestige Brands Holdings, Inc. Reported	Dec. 31, 2011 Prestige Brands Holdings, Inc. Reported	Mar. 31, 2012 Prestige Brands Holdings, Inc. Reported	Dec. 31, 2012 Prestige Brands Holdings, Inc. Revised	Jun. 30, 2012 Prestige Brands Holdings, Inc. Revised	Dec. 31, 2011 Prestige Brands Holdings, Inc. Revised	Mar. 31, 2012 Prestige Brands Holdings, Inc. Revised	Jun. 30, 2012 Prestige Brands Holdings, Inc. Adjustment	Dec. 31, 2012 Prestige Brands, Inc., the issuer	Dec. 31, 2011 Prestige Brands, Inc., the issuer	Dec. 31, 2012 Prestige Brands, Inc., the issuer	Dec. 31, 2011 Prestige Brands, Inc., the issuer	Mar. 31, 2012 Prestige Brands, Inc., the issuer	Dec. 31, 2012 Prestige Brands, Inc., the issuer Reported	Dec. 31, 2011 Prestige Brands, Inc., the issuer Reported	Mar. 31, 2012 Prestige Brands, Inc., the issuer Reported	Dec. 31, 2012 Prestige Brands, Inc., the issuer Revised	Jun. 30, 2012 Prestige Brands, Inc., the issuer Revised	Dec. 31, 2011 Prestige Brands, Inc., the issuer Revised	Mar. 31, 2012 Prestige Brands, Inc., the issuer Revised	Jun. 30, 2012 Prestige Brands, Inc., the issuer Adjustment	Dec. 31, 2012 Combined Subsidiary Guarantors	Dec. 31, 2011 Combined Subsidiary Guarantors	Dec. 31, 2012 Combined Subsidiary Guarantors	Dec. 31, 2011 Combined Subsidiary Guarantors	Mar. 31, 2012 Combined Subsidiary Guarantors	Dec. 31, 2012 Combined Subsidiary Guarantors Reported	Dec. 31, 2011 Combined Subsidiary Guarantors Reported	Mar. 31, 2012 Combined Subsidiary Guarantors Reported	Dec. 31, 2012 Combined Subsidiary Guarantors Revised	Dec. 31, 2011 Combined Subsidiary Guarantors Revised	Mar. 31, 2012 Combined Subsidiary Guarantors Revised	Dec. 31, 2012 Combined Non-Guarantor Subsidiaries	Dec. 31, 2011 Combined Non-Guarantor Subsidiaries	Dec. 31, 2012 Combined Non-Guarantor Subsidiaries	Dec. 31, 2011 Combined Non-Guarantor Subsidiaries	Mar. 31, 2012 Combined Non-Guarantor Subsidiaries	Dec. 31, 2012 Combined Non-Guarantor Subsidiaries Reported	Dec. 31, 2011 Combined Non-Guarantor Subsidiaries Reported	Mar. 31, 2012 Combined Non-Guarantor Subsidiaries Reported	Dec. 31, 2012 Combined Non-Guarantor Subsidiaries Revised	Dec. 31, 2011 Combined Non-Guarantor Subsidiaries Revised	Mar. 31, 2012 Combined Non-Guarantor Subsidiaries Revised	Dec. 31, 2012 Eliminations	Dec. 31, 2011 Eliminations	Dec. 31, 2012 Eliminations	Dec. 31, 2011 Eliminations	Mar. 31, 2012 Eliminations	Dec. 31, 2012 Eliminations Reported	Dec. 31, 2011 Eliminations Reported	Mar. 31, 2012 Eliminations Reported	Dec. 31, 2012 Eliminations Revised	Dec. 31, 2011 Eliminations Revised	Mar. 31, 2012 Eliminations Revised
Income Statement [Abstract]
Revenue	$ 160,232	$ 106,250	$ 469,084	$ 307,089		$ 0	$ 0	$ 0	$ 0		$ 0	$ 0		$ 0		$ 0			$ 25,424	$ 27,409	$ 75,514	$ 74,945		$ 83,768	$ 232,214		$ 27,409		$ 74,945			$ 133,605	$ 77,759	$ 390,125	$ 229,245		$ 21,343	$ 71,823		$ 77,759	$ 229,245		$ 1,542	$ 1,366	$ 4,896	$ 4,183		$ 1,423	$ 4,336		$ 1,366	$ 4,183		$ (339)	$ (284)	$ (1,451)	$ (1,284)		$ (284)	$ (1,284)		$ (284)	$ (1,284)
Income before income taxes	20,061	15,514	75,542	60,357		8,262	8,782	43,704	41,445		13,575	52,806		8,782		41,445			25,355	13,876	53,197	36,243		6,402	20,701		13,876		36,243			13,324	11,501	77,479	36,487		(1,316)	(2,163)		11,501	36,487		451	(21)	1,756	1,133		(22)	1,132		(21)	1,133		(27,331)	(18,624)	(100,594)	(54,951)		(3,125)	(12,119)		(18,624)	(54,951)
Provision (benefit) for income taxes	7,804	6,004	29,386	23,130		(3,995)	(728)	(2,452)	4,218		4,065	15,579		(728)	600	4,218		4,300	6,593	2,285	1,524	4,781		2,430	8,000		2,285	(3,000)	4,781		(4,400)	5,030	4,454	29,631	13,697		(509)	(837)		4,454	13,697		176	(7)	683	434		18	388		(7)	434		0	0	0	0		0	0		0	0
Net income	12,257	9,510	46,156	37,227		12,257	9,510	46,156	37,227		9,510	37,227		9,510		37,227			18,762	11,591	51,673	31,462		3,972	12,701		11,591		31,462			8,294	7,047	47,848	22,790		(807)	(1,326)		7,047	22,790		275	(14)	1,073	699		(40)	744		(14)	699		(27,331)	(18,624)	(100,594)	(54,951)		(3,125)	(12,119)		(18,624)	(54,951)
Statement of Financial Position [Abstract]
Total current assets	151,222		151,222		147,035	10,887		10,887		26,704			26,704				26,704		23,712		23,712		22,505			98,887				22,505		113,398		113,398		95,240			19,222			95,240	3,225		3,225		2,586			2,222			2,586	0		0		0			0			0
Total assets	1,731,389		1,731,389		1,758,276	2,112,666		2,112,666		2,065,825			2,200,652				2,065,825		2,866,770		2,866,770		2,939,785			3,236,598				2,939,785		1,824,454		1,824,454		1,729,776			267,407			1,729,776	11,096		11,096		8,900			10,402			8,900	(5,083,597)		(5,083,597)		(4,986,010)			(3,956,783)			(4,986,010)
Total current liabilities	88,750		88,750		63,923	12,846		12,846		16,289			16,779				16,289		23,409		23,409		20,392			49,246				20,392		49,970		49,970		25,952			(3,446)			25,952	2,525		2,525		1,290			1,344			1,290	0		0		0			0			0
Total liabilities	1,274,057		1,274,057		1,355,548	1,655,334		1,655,334		1,663,097			1,797,927				1,663,097		1,526,032		1,526,032		1,650,946			2,982,492				1,650,946		1,736,129		1,736,129		489,526			196,430			489,526	2,785		2,785		1,685			2,116			1,685	(3,646,223)		(3,646,223)		(2,449,706)			(3,623,417)			(2,449,706)
Total Stockholders' Equity	457,332		457,332		402,728	457,332		457,332		402,728			402,725				402,728		1,340,738		1,340,738		1,288,839			254,106				1,288,839		88,325		88,325		1,240,250			70,977			1,240,250	8,311		8,311		7,215			8,286			7,215	(1,437,374)		(1,437,374)		(2,536,304)			(333,366)			(2,536,304)
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities			100,876	47,993				2,992	13,742			54,406				13,742					16,660	1,613			(4,109)				1,613					78,746	31,548			0			31,548				2,478	1,090			169			1,090				0	0			(2,473)			0
Net cash provided by (used in) investing activities			12,567	842				(9,148)	1,060			1,060				1,060					0	0			(218)				0					21,715	(218)			0			(218)				0	0			0			0				0	0			0			0
Net cash provided by (used in) financing activities			$ (122,040)	$ (57,699)				$ (3,187)	$ (23,955)			$ (64,619)				$ (23,955)					$ (16,660)	$ (1,613)			$ 4,327				$ (1,613)					$ (100,461)	$ (31,330)			$ 0			$ (31,330)				$ (1,732)	$ (801)			$ 120			$ (801)				$ 0	$ 0			$ 2,473			$ 0